Form990
Click to see attachment
Department of the Treasury
Internal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private
foundations)
MediumBullet Do not enter social security numbers on this form as it may be made public.
MediumBullet Information about Form 990 and its instructions is at www.IRS.gov/form990.
OMB No. 1545-0047
2014
Open to Public Inspection
A For the 2014 calendar year, or tax year beginning 07-01-2014 , and ending 06-30-2015
BCheck if applicable:
CName of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Doing business as
 
 
Number and street (or P.O. box if mail is not delivered to street address)
1311 MAMARONECK AVENUE - SUITE 310
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
WHITE PLAINS, NY10605
D Employer identification number

13-5644916
E Telephone number

G Gross receipts $ 387,950,949
F Name and address of principal officer:
LOUIS J DEGENNARO PRESIDENT CEO
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.LLS.ORG
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:
 
L Year of formation: 1949
M State of legal domicile: NY
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 29
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 29
5 Total number of individuals employed in calendar year 2014 (Part V, line 2a) ...... 5 1,321
6 Total number of volunteers (estimate if necessary) ............. 6 3,000,000
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 0
b Net unrelated business taxable income from Form 990-T, line 34 ......... 7b  
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 302,437,152 283,909,984
9 Program service revenue (Part VIII, line 2g) .........   0
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 6,995,117 4,913,321
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 663,718 -7,194,375
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)................... 310,095,987 281,628,930
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 130,249,475 107,996,054
14 Benefits paid to or for members (Part IX, column (A), line 4).....   0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 94,185,722 85,679,493
16a Professional fundraising fees (Part IX, column (A), line 11e)..... 7,178,370 4,709,809
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet42,413,663    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 85,584,715 79,057,701
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 317,198,282 277,443,057
19 Revenue less expenses. Subtract line 18 from line 12....... -7,102,295 4,185,873
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 242,581,527 214,485,806
21 Total liabilities (Part X, line 26)............. 145,444,419 116,963,860
22 Net assets or fund balances. Subtract line 21 from line 20..... 97,137,108 97,521,946
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name MediumBullet
Firm's EIN MediumBullet
Firm's address MediumBullet



Phone no.
May the IRS discuss this return with the preparer shown above? (see instructions) ..........
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y Form 990 (2014)
Form 990 (2014)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III ..............
1
Briefly describe the organization’s mission: OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? ......................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program services? ............................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 69,238,255 including grants of $ 65,760,793 ) (Revenue $   )
A) RESEARCH PROGRAMS: WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, LLS FUNDS EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVED OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. LLS IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE. TO DATE, LLS HAS INVESTED OVER 1 BILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2015, LLS SUPPORTED RESEARCH IN THE U.S., CANADA AND 7 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY 65 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: - BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. - TURNING DISCOVERIES INTO NEW THERAPIES: FUNDAMENTAL NEW FINDINGS CAN BE TRANSLATED INTO SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. - SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. - FILLING A VOID: RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY GOVERNMENT AGENCIES OR FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. - SPEEDING NEW TREATMENTS TO PATIENTS: PARTNERING WITH BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES CAN ADVANCE PROMISING THERAPIES THROUGH CLINICAL TESTING, FASTER. PAST ADVANCES MADE WITH LLS RESEARCH FUNDING GENEROUS DONORS HAVE HELPED LLS SUPPORT RESEARCH THAT HAS ALREADY BENEFITED BLOOD CANCER PATIENTS AND MANY OTHERS. ADVANCES INCLUDE: - MULTI-DRUG THERAPIES THAT ARE MORE EFFECTIVE THAN TREATMENTS WITH SINGLE ANTI-CANCER AGENTS, - BONE MARROW / STEM CELL TRANSPLANTATION AND SUPPORTIVE CARE TREATMENTS FOR PATIENTS WHO RELAPSE DESPITE THE BEST AVAILABLE THERAPY, AND, - TESTS THAT DISTINGUISH SPECIFIC CHARACTERISTICS OF PARTICULAR BLOOD CANCERS FOR ACCURATE DIAGNOSIS OF CANCER SUBTYPES, AND FOR "RISK STRATIFICATION" TO SELECT AN OPTIMAL THERAPY. TARGETED THERAPY RESEARCH DISCOVERING THE MOLECULAR ABNORMALITIES THAT CAUSE PARTICULAR TYPES OF BLOOD CANCER HAS BEEN USEFUL IN DIAGNOSIS AND RISK STRATIFICATION, AND IN NEW "TARGETED DRUG" DEVELOPMENT. LLS-FUNDED INVESTIGATORS HAVE HELPED ADVANCE MOLECULARLY TARGETED TREATMENTS THAT CAN SELECTIVELY KILL BLOOD CANCER CELLS VERSUS NORMAL CELLS. MANY OF THESE NEW TREATMENTS BENEFIT NOT ONLY BLOOD CANCER PATIENTS, BUT ALSO PATIENTS WITH OTHER DISEASES. FOR EXAMPLE: - GLEEVEC IS FDA-APPROVED FOR PATIENTS OF ALL AGES WITH CHRONIC MYELOID LEUKEMIA (CML), AND IS ALSO APPROVED FOR PATIENTS WITH ONE FORM OF ACUTE LYMPHOID LEUKEMIA (ALL), MYELODYSPLASTIC SYNDROMES (MDS), MYELOPROLIFERATIVE DISORDERS AND RARE FORMS OF STOMACH AND SKIN CANCERS. RELATED DRUGS, SPRYCEL AND TASIGNA, ARE APPROVED FOR PATIENTS WHO DO NOT BENEFIT FROM GLEEVEC. ONE OR MORE OF THESE DRUGS ARE ALSO SHOWING PROMISE FOR PATIENTS WITH VARIOUS LYMPHOMAS, ACUTE MYELOID LEUKEMIA (AML), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND OTHER CANCERS, INCLUDING BRAIN, BREAST, HEAD-AND-NECK, LUNG, PANCREATIC, AND PROSTATE CANCERS, AND PATIENTS WITH OTHER DISEASES INCLUDING ALZHEIMER'S, ASTHMA AND PULMONARY HYPERTENSION. - RITUXAN WAS THE FIRST FDA-APPROVED, ANTI-CANCER ANTIBODY DRUG, DEVELOPED FOR PATIENTS WITH FORMS OF B-CELL NON-HODGKIN LYMPHOMA (NHL). IT IS NOW ALSO APPROVED FOR CLL PATIENTS AND AS A "MAINTENANCE" THERAPY FOR FOLLICULAR LYMPHOMA PATIENTS, AND SHOWING PROMISE FOR PATIENTS WITH ALL AND AFTER STEM CELL TRANSPLANTATION. IN ADDITION, IT IS APPROVED FOR TREATING PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS AND TWO OTHER TYPES OF AUTOIMMUNE DISEASES. A RELATED ANTIBODY DRUG, ARZERRA, IS APPROVED FOR CLL PATIENTS AND SHOWING WIDER PROMISE. - VELCADE, THALIDOMID AND REVLIMID ARE FDA-APPROVED FOR PATIENTS WITH MYELOMA AND ARE ALSO HELPING SOME PATIENTS WITH HODGKIN LYMPHOMA AND NHL. KRYPOLIS WAS RECENTLY APPROVED FOR MYELOMA PATIENTS FOR WHOM AT LEAST TWO PRIOR THERAPIES WERE INSUFFICIENT. ONE OR MORE OF THESE DRUGS ARE NOW BEING TESTED FOR PATIENTS WITH T-CELL AND B-CELL FORMS OF LYMPHOMA, ACUTE LEUKEMIAS, AS WELL AS AIDS-RELATED KAPOSI SARCOMA AND BRAIN, BREAST, COLORECTAL, HEAD-AND-NECK, KIDNEY, LIVER, LUNG, OVARIAN AND PROSTATE CANCERS, AND ALZHEIMER'S DISEASE. - ISTODAX, ZOLINZA, DACOGEN AND VIDAZA TARGET SMALL CHEMICAL, "EPIGENETIC" CHANGES. THE FIRST TWO DRUGS ARE APPROVED FOR PATIENTS WITH PERIPHERAL T-CELL LYMPHOMAS; THE LATTER DRUGS ARE APPROVED FOR MDS PATIENTS. ONE OR MORE OF THESE DRUGS ARE BEING TESTED FOR PATIENTS WITH ALL, AML, CML, CLL, MYELOMA AND FORMS OF NHL, AFTER STEM CELL TRANSPLANTATION, AND FOR PATIENTS WITH BREAST, BRAIN, KIDNEY, COLORECTAL, HEAD-AND-NECK, LUNG, STOMACH, PROSTATE AND OVARIAN CANCERS, MELANOMA AS WELL AS SICKLE CELL DISEASE AND PERSISTENT HIV INFECTIONS. - ADCETRIS WAS APPROVED IN 2011, AND IN JANUARY 2012. IT IS AN ANTIBODY- DRUG CONJUGATE THAT COMBINES AN ANTI-CD30 ANTIBODY AND THE CYTOTOXIC DRUG MONOMETHYL AURISTATIN E (MMAE). IT IS AN ANTI-NEOPLASTIC AGENT USED IN THE TREATMENT OF HODGKIN LYMPHOMA AFTER FAILURE OF AUTOLOGOUS STEM CELL TRANSPLANT OR THOSE WHO ARE NOT ELIGIBLE FOR ASCT AFTER FAILURE OF AT LEAST 2 MUTIAGEN CHEMOTHERAPY REGIMENS. ADCETRIS WAS ALSO APPROVED FOR SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA WITH FAILURE OF AT LEAST ONE PRIOR TREATMENT. - GAZYVA IS A HUMANIZED MONOCLONAL ANTIBODY USED AS A COMBINATION TREATMENT WITH CHLORAMBUCIL TO TREAT PATIENTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA. IT WAS APPROVED BY THE FDA IN NOVEMBER 2013 AND BY THE EHA IN JULY 2014. - IMBRUVICA IS AN ORAL SMALL MOLECULE INHIBITOR AGIANST BTK KINASE. IT WAS FIRST APPROVED BY THE US FDA ON NOVEMBER 13, 2013 FOR THE TREATMENT OF MANTLE CELL LYMPHOMA PATIENTS WHO HAVE RECIEVED AT LEAST ONE PRIOR TREATMENT. ON FEB. 12, 2014 THE US FDA EXPANDED THE APPROVED USE OF THE DRUG TO CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR TREATMENT. ADDITIONALLY, IT RECEIVED FURTHER EXPANSION TO TREAT 17P DELETION IN CLL WITH OR WITHOUT PRIOR THERAPY. - ZYDELIG IS AN ORAL SMALL MOLECULE INHIBITOR THAT BLOCKS THE DELTA ISOFORM OF THE ENZYME PHOSPHOINOSITIDE 3-KINASE. IT WAS APPROVED BY THE FDA IN JULY 2014 TO TREAT RELAPSED/REFRACTORY CLL IN COMBINATION WITH RITUXAN. IT WAS ALSO APPROVED TO USE AS A MONOTHERAPY FOR RELAPSED MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA. OTHER ACTIVE RESEARCH DIRECTIONS LLS-FUNDED RESEARCHERS ARE ALSO EXPLORING OTHER AREAS OF RESEARCH THAT HOLD PROMISE FOR PATIENTS: - NOVEL STEM CELL TRANSPLANTATION PROCEDURES: THESE INCLUDE SO-CALLED "MINI" TRANSPLANTS THAT USE LESS TOXIC PRE-TRANSPLANT TREATMENTS AND ENGINEERED DONOR CELLS THAT HELP REDUCE POST-TRANSPLANT COMPLICATIONS, MAKING THESE POTENTIALLY CURATIVE TREATMENTS AVAILABLE TO MORE PATIENTS. - IMMUNOTHERAPIES: INCLUDING ANTIBODIES, VACCINES AND ENGINEERED IMMUNE CELLS, THESE TARGETED THERAPIES HELP A PATIENT'S IMMUNE SYSTEM FIGHT INFECTIONS AND KILL RESIDUAL CANCER CELLS, PROLONGING REMISSIONS, AND PERHAPS ONE DAY REPLACING TOXIC CHEMOTHERAPIES. - DIAGNOSTICS: NEW TECHNOLOGIES MAKE IT POSSIBLE TO CHARACTERIZE THE ABNORMALITIES IN INDIVIDUAL CANCER CASES IN MOLECULAR DETAIL. THIS INFORMATION CAN BE USED TO HELP CHOOSE THE BEST POSSIBLE TREATMENT FOR EACH PATIENT, ESPECIALLY AS MORE TARGETED THERAPIES BECOME AVAILABLE. - QUALITY OF LIFE RESEARCH: THESE STUDIES INCREASE OUR UNDERSTANDING OF HOW SPECIFIC TREATMENTS CAN CAUSE DEBILITATING SIDE-EFFECTS, INCLUDING LATE-EFFECTS, AND WHICH PATIENTS ARE AT RISK FOR DEVELOPING THESE COMPLICATIONS, SO THAT THEY CAN BE BETTER MANAGED OR EVEN PREVENTED. DRIVING RESEARCH TO ADDRESS UNMET MEDICAL NEEDS LLS CONTINUES TO SOLICIT AND SUPPORT RESEARCH FOCUSED ON IMPROVING BLOOD CANCER PATIENTS' QUALITY OF LIFE AFTER TODAY'S CURATIVE THERAPIES. ALSO IN 2015, FOR THE FOURTH YEAR, LLS ACTIVELY RECRUITED RESEARCH PROPOSALS IN SIX OTHER UNDERDEVELOPED RESEARCH AREAS IN WHICH PROGRESS IS LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. NEW RESEARCH IS FOCUSED ON: - DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES FOR PATIENTS WITH NON- CUTANEOUS T-CELL LYMPHOPROLIFERATIVE DISORDERS - DEVELOP NOVEL TARGETED THERAPIES FOR CLL PATIENTS, WITH REAL CURATIVE POTENTIAL - DEVELOP NOVEL TREATMENT STRATEGIES FOR MDS AND AML PATIENTS - DEVELOP NOVEL TARGETED THERAPIES FOR PATIENTS WITH HIGH-RISK MYELOMA - DEVELOPMENT OF NEW-TARGETED THERAPIES FOR INDOLENT LYMPHOMA PATIENTS - DEFINE GENETIC/MOLECULAR PREDISPOSITIONS TO LONG-TERM AND LATE-
4b (Code:   ) (Expenses $ 86,747,069 including grants of $ 42,235,261 ) (Revenue $   )
B) PATIENT & COMMUNITY SERVICES: AN ESTIMATED 1.2 MILLION PEOPLE ACROSS THE UNITED STATES (US) CURRENTLY BATTLE LEUKEMIA, LYMPHOMA AND MYELOMA. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) OFFERS A FREE, COMPREHENSIVE ARRAY OF SERVICES TO BLOOD CANCER PATIENTS AND THEIR FAMILIES, VOLUNTEER CAREGIVERS AND ADVOCATES, HEALTHCARE PROFESSIONALS AND THE PUBLIC. LLS IS COMMITTED TO PROVIDING THE MOST ACCURATE AND UP-TO-DATE BLOOD CANCER INFORMATION. PROFESSIONAL VOLUNTEER CLINICAL ADVISORS WORK WITH LLS STAFF TO REVIEW ALL OF THE INFORMATION LLS PROVIDES THROUGH HEALTHCARE PROFESSIONAL AND PATIENT EDUCATION PROGRAMS, PUBLICATIONS AND THE LLS WEBSITE. A NUMBER OF RESOURCES ARE AVAILABLE IN SPANISH FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS. LLS PUBLISHES AN ANNUAL COMPILATION OF DATA AVAILABLE FOR BLOOD CANCERS, INCLUDING THE ESTIMATED NUMBERS OF NEW BLOOD CANCER CASES AND DEATHS, THE MOST RECENT STATISTICS AVAILABLE FOR INCIDENCE, MORTALITY AND SURVIVAL; AND CURRENT AND ACCURATE INFORMATION ABOUT SYMPTOMS, RISK FACTORS AND TREATMENT. PUBLICATIONS AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LLS CHAPTERS. MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH, SPANISH AND FRENCH. - 705,326 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2015. FINANCIAL ASSISTANCE IN 2015, A COMBINED 42,235,261 WAS DISBURSED TO PATIENTS THROUGH THE LLS PATIENT FINANCIAL AID (111,525),CO-PAY ASSISTANCE PROGRAMS (41,805,481) AND THE LLS NATIONAL PATIENT TRAVEL ASSISTANCE PROGRAM (318,255). CO-PAY ASSISTANCE PROGRAM THIS CO-PAY ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 19,922 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2015 COMMUNITY PROGRAMS EACH LLS CHAPTER OFFICE IS STAFFED WITH A PATIENT SERVICES MANAGER (PSM) WHO OVERSEES SERVICES TO PATIENTS AND THEIR FAMILIES, CAREGIVERS AND HEALTHCARE PROFESSIONALS. PSMS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. PSMS SERVE AS LIAISONS WITH COMMUNITY AND REGIONAL ONCOLOGY/HEMATOLOGY HEALTHCARE PROFESSIONALS AND TREATMENT CENTERS. COMMUNITY-BASED EDUCATION AND OUTREACH, SUPPORT AND PUBLIC POLICY AND ADVOCACY PROGRAMS ARE AVAILABLE. PATIENT EDUCATION PROGRAMS: IN 2015 WE CONDUCTED 221 LOCAL PATIENT EDUCATION PROGRAMS TO A TOTAL OF 9,807 ATTENDEES. THESE PROGRAMS RANGED FROM DISEASE SPECIFIC TOPICS TO THOSE OF SURVIVORSHIP. OF THE TOTAL ATTENDING THESE LOCAL EDUCATION PROGRAMS, A MAJORITY WERE PATIENTS AND CAREGIVERS (6,872 ATTENDEES) BUT IMPORTANTLY, MANY (2,404 ATTENDEES) WERE HEALTHCARE PROFESSIONALS. BLOOD CANCER CONFERENCES: LLS WORKS TO ELEVATE OUR VISIBILITY IN COMMUNITIES WE SERVE BY HOSTING LARGER-SCALE CONFERENCES, GEARED FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS. THESE EVENTS ARE A CATALYST FOR BRINGING MANY DEDICATED PEOPLE TOGETHER TO FOCUS ON BLOOD CANCER AWARENESS, INFORMATION AND THE LATEST ADVANCES IN MEDICAL SCIENCE. THEY ARE ALSO AN IMPORTANT SOURCE OF CONTINUING EDUCATION FOR MANY HEALTHCARE PROFESSIONALS. IN 2015, 25 BCC CONFERENCES WERE HELD WITH TOTAL ATTENDANCE OF 6,589. 2,965 WERE PATIENTS, 1,511 CAREGIVERS, 1,001 NURSES, 181 SOCIAL WORKS, 128 MEDICAL DOCTORS, AND 628 "OTHER" HEALTHCARE PROFESSIONALS SERVING THE UNDERSERVED: IN 2015, WE OFFERED 68 SPECIAL PROGRAMS TO PEOPLE WHO OFTEN DON'T HAVE THE SAME ACCESS TO INFORMATION AND SUPPORT AS OTHERS MIGHT HAVE. BREAKING DOWN ACCESS BARRIERS IN UNDERREPRESENTED POPULATIONS MEANS BLOOD CANCER PATIENTS GET THE INFORMATION AND SUPPORT THEY NEED. THIS OUTREACH BROUGHT IMPORTANT DISEASE TREATMENT INFORMATION TO MORE THAN 5,500 PEOPLE IN COMMUNITIES WE SERVE. OF THIS, 3,870 WERE PATIENTS AND CAREGIVERS, JOINED BY 1,126 HEALTHCARE PROFESSIONALS. MYELOPROLIFERATIVE NEOPLASMS OR MPN: IN 2015, LLS WAS ABLE TO OFFER SPECIALIZED MYELOPROLIFERATIVE NEOPLASMS OR MPN EDUCATION PROGRAMS IN FOUR COMMUNITIES TO A TOTAL OF 70 PATIENTS AND CAREGIVERS AND 9 HEALTHCARE PROFESSIONALS. IN ADDITION, LLS PROVIDED COMMUNITY-BASED EDUCATION CONCERNING THE LATEST CLINICAL TRIALS INFORMATION TO 634 PATIENTS AND CAREGIVERS, WHO WERE JOINED BY 286 HEALTHCARE PROFESSIONALS. FAMILY SUPPORT GROUPS: THROUGHOUT THE US, IN 2015, LLS SUPPORTED OR HOSTED 296 REGISTERED FAMILY SUPPORT GROUP MEETINGS FOR PATIENTS AND THEIR FAMILIES. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, PROVIDING INFORMATION AND SUPPORT AND ENCOURAGING GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTHCARE PROFESSIONALS. LLS SUPPORT GROUPS ARE THE PERFECT PLACE TO TALK WITH OTHER PEOPLE AFFECTED BY BLOOD CANCERS, INCLUDING PATIENTS, FAMILY MEMBERS AND CAREGIVERS. THE GROUPS PROVIDE MUTUAL SUPPORT AND OFFER THE OPPORTUNITY TO DISCUSS ANXIETIES AND CONCERNS WITH OTHERS WHO SHARE THE SAME EXPERIENCES. THIS SHARING STRENGTHENS THE FAMILY BOND AND ENHANCES EVERYONE'S ABILITY TO COPE WITH CANCER. PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM: FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 1,476 FIRST CONNECTIONS ACROSS THE US IN 2015.
4c (Code:   ) (Expenses $ 33,246,948 including grants of $   ) (Revenue $   )
C) PUBLIC HEALTH EDUCATION: INFORMATION AND EDUCATION. INFORMATION RESOURCE CENTER. PAYING FOR MEDICAL CARE, MAKING TREATMENT CHOICES, COMMUNICATING WITH HEALTHCARE PROVIDERS, FAMILY MEMBERS AND FRIENDS-THESE ARE SOME OF THE STRESSES THAT COME WITH A CANCER DIAGNOSIS. LLS INFORMATION SPECIALISTS ARE MASTER'S LEVEL ONCOLOGY SOCIAL WORKERS, NURSES AND HEALTH EDUCATORS WHO PROVIDE HELP WITH DISEASE, TREATMENT AND CLINICAL TRIAL INFORMATION AND SUPPORT. LLS INFORMATION SPECIALISTS CONDUCT CLINICAL-TRIAL SEARCHES TO HELP PATIENTS WORK WITH THEIR DOCTORS TO FIND OUT ABOUT SPECIFIC CLINICAL TRIALS. PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 9 P.M., ET, EMAIL INFOCENTER@LLS.ORG OR CHAT ONE-ON-ONE VIA THE LLS WEBSITE. THE INFORMATION RESOURCE CENTER OFFERS TRANSLATION SERVICES IN MORE THAN 165 LANGUAGES. - 31,511 INQUIRIES MADE TO OUR INFORMATION SPECIALISTS, AND 30,871 INQUIRIES MADE TO OUR PATIENT ACCESS STAFF ACROSS THE COUNTRY IN 2015. THE LLS WEBSITE THE LLS WEBSITE, WWW.LLS.ORG, FULFILLS A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. VISITORS CAN PERSONALIZE THEIR WEB PAGES TO THEIR LOCATION TO KEEP CURRENT WITH DISEASE-SPECIFIC UPDATES AND COMMUNITY EDUCATION AND SUPPORT ACTIVITIES. THE WEBSITE PROVIDES ACCESS TO LLS PROGRAMS AND SERVICES, INCLUDING CO-PAY ASSISTANCE, THE MOST CURRENT AND ACCURATE INFORMATION AND STATISTICS, WEEKLY FACILITATED ONLINE CHATS, NATIONAL TELEPHONE AND WEB EDUCATION PROGRAMS, PUBLICATIONS IN ENGLISH AND SPANISH, AND CLINICAL-TRIAL SEARCHES VIA AN ONLINE CLINICAL- TRIAL SEARCH SERVICE THAT OFFERS PATIENTS AND CAREGIVERS IMMEDIATE ACCESS TO LISTINGS OF BLOOD CANCER CLINICAL TRIALS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS AND ONE ANOTHER THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. NATIONAL TELEPHONE/ WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. IN 2015, 9 LLS NATIONAL EDUCATION PROGRAMS FEATURED DISEASE-SPECIFIC UPDATES AND INFORMATION ABOUT SUPPORT AND TREATMENT OPTIONS FROM WORLD RENOWNED CLINICAL EXPERTS. OPPORTUNITIES ARE PROVIDED TO ASK QUESTIONS OF EXPERTS DURING THESE PROGRAMS. THESE PROGRAMS OFFER CONTINUING EDUCATION CREDITS FOR NURSES AND SOCIAL WORKERS. LLS ALSO SPONSORS A RANGE OF PROFESSIONAL EDUCATION PROGRAMS. RECENT PROGRAMS EXPLORED THE ADMINISTRATION AND MANAGEMENT OF CURRENT THERAPIES FOR HEMATOLOGIC MALIGNANCIES AND COMMUNICATION AMONG PRIMARY CARE PROVIDERS AND HEMATOLOGISTS/ONCOLOGISTS IN MANAGING PATIENTS WITH HEMATOLOGIC CANCER. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. PROFESSIONAL EDUCATION PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PROFESSIONALED. LLS ALSO OFFERS DISEASE-SPECIFIC WEBCASTS PRESENTED BY WORLD RENOWNED CLINICAL EXPERTS. THESE CAN BE ACCESSED AT WWW.LLS.ORG/WEBCASTS.
(Code:   ) (Expenses $ 16,562,341 including grants of $   ) (Revenue $   )
D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT.
4d Other program services (Describe in Schedule O.)
(Expenses $ 16,562,341 including grants of $   ) (Revenue $   )
4e Total program service expensesMediumBullet205,794,613
Form 990 (2014)
Form 990 (2014)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule AClick to see attachment........................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? Click to see attachment...
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part IClick to see attachment..........
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part IIClick to see attachment........
4
Yes
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes," complete Schedule C,
Part IIIClick to see attachment............................
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part IClick to see attachment........................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part IIClick to see attachment...
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes," complete Schedule D, Part III Click to see attachment....................
8
Yes
 
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IVClick to see attachment..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi-endowments? If "Yes," complete Schedule D, Part VClick to see attachment......
10
Yes
 
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10?
If "Yes," complete Schedule D, Part VI.Click to see attachment...................
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIClick to see attachment.......
11b
Yes
 
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIIClick to see attachment.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IXClick to see attachment............
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part XClick to see attachment
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment.........................
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year?
If "Yes," complete Schedule D, Parts XI and XII Click to see attachment.................
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E....
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States?.....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV......... Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IVClick to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV... Click to see attachment
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I (see instructions) .... Click to see attachment
17
Yes
 
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............ Click to see attachment
18
Yes
 
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III................... Click to see attachment
19
Yes
 
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
Form 990 (2014)
Form 990 (2014)
Page 4
Part IV
Checklist of Required Schedules (continued)
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.. Click to see attachment
21
Yes
 
22
Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........ Click to see attachment
22
Yes
 
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a................
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds?......................
24c
 
 
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I....
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I...................
25b
 
No
26
Did the organization report any amount on Part X, line 5, 6, or 22 for receivables from or payables to any current or former officers, directors, trustees, key employees, highest compensated employees, or disqualified persons? If "Yes," complete Schedule L, Part II................
26
 
No
27
Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor or employee thereof, a grant selection committee member, or to a 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part III.........
27
 
No
28
Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, or key employee? If "Yes," complete Schedule L, Part IV ..........................
28a
 
No
b
A family member of a current or former officer, director, trustee, or key employee? If "Yes,"
complete Schedule L, Part IV.....................
28b
 
No
c
An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or direct or indirect owner? If "Yes," complete Schedule L, Part IV...
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..Click to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M............. Click to see attachment
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N,
Part I...........................
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II......................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I........ Click to see attachment
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1........................ Click to see attachment
34
Yes
 
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
Yes
 
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2... Click to see attachment
35b
Yes
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2............. Click to see attachment
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VIClick to see attachment
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Form 990 (2014)
Form 990 (2014)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V ..............
Yes
No
1a
Enter the number reported in Box 3 of Form 1096 Enter -0- if not applicable ..
1a
845
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable .
1b
23
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
1,321
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
 
No
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
 
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)?..........................
4a
Yes
 
b
If "Yes," enter the name of the foreign country: MediumBulletCA
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year?..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions?...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible?........................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor?....................
7a
Yes
 
b
If "Yes," did the organization notify the donor of the value of the goods or services provided?.....
7b
Yes
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282?...........................
7c
 
No
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?............................
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract?..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required?............................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C?..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds.
Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year?.........................
8
 
 
9a
Did the sponsoring organization make any taxable distributions under section 4966?...
9a
 
 
b
Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year. ....................
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state?
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
Form 990 (2014)
Form 990 (2014)
Page 6
Part VI
Governance, Management, and Disclosure For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI ..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year .....................
1a
29
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent ...................
1b
29
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? ...........................
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
Yes
 
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
Yes
 
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
Yes
 
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .........................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
Yes
 
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
Yes
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe in Schedule O how this was done.......................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
 
No
b
Other officers or key employees of the organization ................
15b
 
No
If "Yes" to line 15a or 15b, describe the process in Schedule O (see instructions).
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the States with which a copy of this Form 990 is required to be filedMediumBullet
AK , AL , AR , AZ , CA , CO , CT , DE , DC , FL , GA , HI , ID , IL , IN , KS , KY , LA , MA , MD , ME , MI , MN , MO , MS , NH , NJ , NM , NE , NY , OH , OK , OR , PA , PR , RI , SC , TN , UT , VA , WA , WI , WV
18
Section 6104 requires an organization to make its Form 1023 (or 1024 if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, address, and telephone number of the person who possesses the organization's books and records:
MediumBulletROSEMARIE LOFFREDO
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605 (914) 949-5213
Form 990 (2014)
Form 990 (2014)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII ..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

List persons in the following order: individual trustees or directors; institutional trustees; officers; key employees; highest
compensated employees; and former such persons.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) LOUIS J DEGENNARO........................................................................
PRESIDENT &
 40.00
.......................1.00 		    X       457,834 0 112,974
(2) ROSEMARIE A LOFFREDO........................................................................
EVP-CAO & CF
 40.00
.......................1.00 		    X       312,192 0 24,816
(3) GORDON MILLER JR........................................................................
SVP FINANCE
 40.00
.......................1.00 		    X       220,116 0 47,340
(4) MARK ROITHMAYR........................................................................
EVP-CHIEF DE
 40.00
.......................   		      X     353,760 0 50,033
(5) GEORGE J OMIROS-TERM APR15........................................................................
EVP-CHIEF CA
 40.00
.......................   		      X     318,316 0 50,125
(6) BRIAN ROSEN - TERM FEB15........................................................................
CHIEF POLICY
 40.00
.......................   		        X   292,610 0 29,649
(7) LEE M GREENBERGER........................................................................
SVP & CHIEF
 40.00
.......................   		        X   284,166 0 42,905
(8) JEFFREY COMO-TERM DEC14........................................................................
CHIEF INFORM
 40.00
.......................   		        X   438,470 0 21,907
(9) LISA STOCKMON - TERM SEPT14........................................................................
EVP-CHIEF MA
 40.00
.......................   		        X   278,930 0 21,359
(10) GABRIELLE URQUHART-TERM JUN15........................................................................
REGIONAL VP
 40.00
.......................   		        X   237,376 0 19,947
(11) JOHN E WALTER - TERM FEB14........................................................................
FORMER PRES
 40.00
.......................1.00 		          X 839,890 0 24,354
(12) JAMES H DAVIS PHD........................................................................
CHAIR
 6.00
.......................2.00 		X   X       0 0 0
(13) ELIZABETH J CLARK........................................................................
VICE CHAIR
 4.00
.......................2.00 		X   X       0 0 0
(14) KENNETH M SCHWARTZ........................................................................
SECRETARY/TR
 4.00
.......................2.00 		X   X       0 0 0
(15) DONALD PROCTOR........................................................................
AT-LARGE
 4.00
.......................2.00 		X   X       0 0 0
(16) JAMES A BECK........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(17) WILLIAM G BEHNKE........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
Form 990 (2014)
Form 990 (2014)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(18) JORGE L BENITEZ........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(19) JAMES E BRADNER........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(20) PETER B BROCK........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(21) DANA A CALLOW JR........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(22) SCOTT A CARROLL........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(23) WILLIAM S DALTON........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(24) TIMOTHY DURST........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(25) GRACIELA C ELETA........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(26) BERNARD H GARIL........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(27) BETH E HAWLEY........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(28) FRANCIE HELLER........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(29) RAANAN HOROWITZ........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(30) RICHARD M JEANNERET........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(31) JOSEPH B KELLEY........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(32) RALPH LAWSON........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(33) MICHELLE LE BEAU........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(34) GILLES LEGAULT........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(35) CONNIE LINDSEY........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(36) STEVEN T ROSEN........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(37) FRANK O SMITH
 
BOD MEMBER
 4.00
.......................   		X           0 0 0
(38) KATHRYN C VECELLIO........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(39) LOUISE G WARNER........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(40) KEITH S WHITE........................................................................
BOD MEMBER
 4.00
.......................   		X           0 0 0
(41) RODMAN N MYERS........................................................................
LIFE MEMBER-
 1.00
.......................   		X           0 0 0
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)............MediumBullet 4,033,660   445,409
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organizationMediumBullet164
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
Yes
 
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
OLIVER STAFFING INC,
350 LEXINGTON AV SUITE 401
NEW YORK,NY10016 		TEMP STAFFING 5,843,380
MAIL AMERICA COMMUNICATIONS,
174 ELKTON FARM RD
FOREST,VA24551 		FUNDRAISING SER 4,304,214
PATIENT ADVOCACY FOUNDATION,
421 BUTLER FARM RD
HAMPTON,VA23666 		PAT ASSIST PROC 4,176,617
RESOLUTE MEDIA LLC,
137 W 25TH ST
NEW YORK,NY10001 		DIGITAL MARKETI 2,100,611
COMPETITOR GROUP,
9477 WAPLES STREET
SAN DIEGO,CA92121 		ENDURANCE SPORT 1,418,995
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet84
Form 990 (2014)
Form 990 (2014)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII .............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512-514
Contributions, Gifts, GrantAmt and OtherAmt Similar Amounts 1a Federated campaigns..1a 1,859,098
b Membership dues....1b  
c Fundraising events....1c 162,196,401
d Related organizations...1d  
e Government grants (contributions)1e  
f All other contributions, gifts, grants, and
similar amounts not included above1f 		119,854,485
g Noncash contributions included in lines
1a-1f:$ 		969,388
h Total. Add lines 1a-1f.......MediumBullet 283,909,984
Program Service RevenueAmt Business Code
2a
b
c
d
e
f All other program service revenue .        
g Total. Add lines 2a–2f........MediumBullet  
OtherAmt RevenueAmt 3 Investment income (including dividends, interest, and other similar amounts).......MediumBullet 1,877,457     1,877,457
4 Income from investment of tax-exempt bond proceeds..MediumBullet        
5 Royalties...........MediumBullet 13,955     13,955
(i) Real (ii) Personal
6a Gross rents    
b Less: rental expenses    
c Rental income or (loss)    
d Net rental income or (loss).......MediumBullet        
(i) Securities (ii) Other
7a Gross amount from sales of assets other than inventory 85,663,036  
b Less: cost or other basis and sales expenses 82,627,172  
c Gain or (loss) 3,035,864  
d Net gain or (loss)..........MediumBullet 3,035,864     3,035,864
8a Gross income from fundraising events (not including
$ 162,196,401
of contributions reported on line 1c). See Part IV, line 18 ..
a 15,797,770
b Less: direct expenses ...b 23,557,444
c Net income or (loss) from fundraising events..MediumBullet -7,759,674   -7,759,674
9a Gross income from gaming activities.
See Part IV, line 19 ...
a 631,918
b Less: direct expenses ...b 137,403
c Net income or (loss) from gaming activities...MediumBullet 494,515     494,515
10a Gross sales of inventory, less
returns and allowances .
a  
b Less: cost of goods sold ..b  
c Net income or (loss) from sales of inventory..MediumBullet        
Miscellaneous Revenue Business Code
11a OTHER MISCELLANEOUS 900099 56,829     56,829
b            
c            
d All other revenue ....        
e Total. Add lines 11a–11d ...... MediumBullet 56,829
12 Total revenue. See Instructions......MediumBullet 281,628,930     -2,281,054
Form 990 (2014)
Form 990 (2014)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX ...............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising expenses
1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 .... 58,051,232 58,051,232
2 Grants and other assistance to domestic individuals. See Part IV, line 22 .... 42,235,261 42,235,261
3 Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines 15 and 16 ............ 7,709,561 7,709,561
4 Benefits paid to or for members ....    
5 Compensation of current officers, directors, trustees, and key employees .... 1,904,623 1,250,249 321,172 333,202
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....        
7 Other salaries and wages .... 68,051,957 44,648,621 11,495,171 11,908,165
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 1,663,579 944,099 409,403 310,077
9 Other employee benefits ....... 9,358,662 5,311,142 2,303,141 1,744,379
10 Payroll taxes ........... 4,700,672 2,667,682 1,156,823 876,167
11 Fees for services (non-employees):        
a Management ......        
b Legal ......... 784,221 491,513 128,390 164,318
c Accounting ........... 292,025 183,027 47,810 61,188
d Lobbying ........... 623,467 390,759 102,073 130,635
e Professional fundraising services. See Part IV, line 17 4,709,809 4,709,809
f Investment management fees ...... 75,197 47,131 12,311 15,755
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) .... 18,219,202 11,418,920 2,982,803 3,817,479
12 Advertising and promotion .... 7,475,264 3,318,576 1,018,944 3,137,744
13 Office expenses ....... 20,158,375 8,691,467 2,271,929 9,194,979
14 Information technology ...... 6,188,376 3,878,576 1,013,146 1,296,654
15 Royalties ..        
16 Occupancy ........... 9,023,616 5,601,465 1,754,904 1,667,247
17 Travel ............ 5,121,398 3,449,430 737,063 934,905
18 Payments of travel or entertainment expenses for any federal, state, or local public officials ......        
19 Conferences, conventions, and meetings .... 2,462,185 1,981,473 263,068 217,644
20 Interest ...........        
21 Payments to affiliates .......        
22 Depreciation, depletion, and amortization ..... 5,721,945 2,068,849 2,473,456 1,179,640
23 Insurance .............. 594,312 247,009 236,700 110,603
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a MISCELLANEOUS 2,027,268 1,079,451 466,829 480,988
b DUES & SUBSCRIPTIONS 290,850 129,120 39,645 122,085
c
d
e All other expenses        
25 Total functional expenses. Add lines 1 through 24e 277,443,057 205,794,613 29,234,781 42,413,663
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720). 12,521,693 2,812,241   9,709,452
Form 990 (2014)
Form 990 (2014)
Page 11
Part X Balance Sheet Check if Schedule O contains a response or note to any line in this Part X ..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing ............. 6,268,949 1 7,141,619
2 Savings and temporary cash investments ......... 20,220,498 2 42,601,449
3 Pledges and grants receivable, net ........... 8,575,572 3 8,633,988
4 Accounts receivable, net ............. 311 4  
5 Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of
Schedule L ..................
  5  
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
  6  
7 Notes and loans receivable, net .............   7  
8 Inventories for sale or use ..............   8  
9 Prepaid expenses and deferred charges .......... 4,955,078 9 5,813,918
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 35,132,960
b Less: accumulated depreciation ..... 10b 20,430,449 16,409,608 10c 14,702,511
11 Investments—publicly traded securities .......... 128,829,280 11 86,639,070
12 Investments—other securities. See Part IV, line 11 ..... 57,322,231 12 48,953,251
13 Investments—program-related. See Part IV, line 11 .....   13  
14 Intangible assets ...............   14  
15 Other assets. See Part IV, line 11 ...........   15  
16 Total assets. Add lines 1 through 15 (must equal line 34)...... 242,581,527 16 214,485,806
Liabilities 17 Accounts payable and accrued expenses ......... 20,275,231 17 17,799,196
18 Grants payable ................. 99,130,986 18 81,859,872
19 Deferred revenue ................ 26,038,202 19 17,304,792
20 Tax-exempt bond liabilities .............   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D..   21  
22 Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
persons. Complete Part II of Schedule L..........   22  
23 Secured mortgages and notes payable to unrelated third parties ..   23  
24 Unsecured notes and loans payable to unrelated third parties ....   24  
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................   25  
26 Total liabilities. Add lines 17 through 25......... 145,444,419 26 116,963,860
Net Assets or Fund Balance Organizations that follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 27 through 29, and lines 33 and 34.
27 Unrestricted net assets .............. 67,582,758 27 71,640,456
28 Temporarily restricted net assets ........... 26,592,408 28 22,847,577
29 Permanently restricted net assets ........... 2,961,942 29 3,033,913
Organizations that do not follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 30 through 34.
30 Capital stock or trust principal, or current funds ........   30  
31 Paid-in or capital surplus, or land, building or equipment fund .....   31  
32 Retained earnings, endowment, accumulated income, or other funds   32  
33 Total net assets or fund balances ........... 97,137,108 33 97,521,946
34 Total liabilities and net assets/fund balances ........ 242,581,527 34 214,485,806
Form 990 (2014)
Form 990 (2014)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI ..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
281,628,930
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
277,443,057
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
4,185,873
4
Net assets or fund balances at beginning of year (must equal Part X, line 33, column (A)) ..
4
97,137,108
5
Net unrealized gains (losses) on investments ...............
5
-3,934,019
6
Donated services and use of facilities .................
6
 
7
Investment expenses .....................
7
 
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
132,984
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 33, column (B))
10
97,521,946
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII .............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133? .................
3a
 
No
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
 
 
Form 990 (2014)
Form 990 (2014)
Page 13
Form 990, Special Condition Description:
Special Condition Description
Form 990 (2014)
Form 990 (2014)
Page 14
Additional Data


Software ID:  
Software Version:  
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support
Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ.
right arrow Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions.
The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)
1
2
3
4
5
section 170(b)(1)(A)(iv). (Complete Part II.)
6
7
8
9
receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of
its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses
acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)
10
11
a
b
c
d
e
f
Enter the number of supported organizations .............................  
g
Provide the following information about the supported organization(s).
(i)Name of supported organization (ii) EIN (iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) (iv) Is the organization listed in your governing document? (v) Amount of monetary support (see instructions) (vi) Amount of other support (see instructions)
Yes No
Total    

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990EZ.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2014
Schedule A (Form 990 or 990-EZ) 2014
Page 2
Part II
Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2010 (b) 2011 (c) 2012 (d) 2013 (e) 2014 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... 270,043,865 282,672,072 279,789,664 302,437,152 283,909,984 1,418,852,737
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3 270,043,865 282,672,072 279,789,664 302,437,152 283,909,984 1,418,852,737
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. 222,588,669
6 Public support. Subtract line 5 from line 4. 1,196,264,068
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2010 (b) 2011 (c) 2012 (d) 2013 (e) 2014 (f) Total
7 Amounts from line 4.. 270,043,865 282,672,072 279,789,664 302,437,152 283,909,984 1,418,852,737
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... 3,145,637 2,705,046 2,260,636 1,203,865 1,891,412 11,206,596
9 Net income from unrelated business activities, whether or not the business is regularly carried on..            
10 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. 1,779,485 1,502,044 1,974,227 104,879 56,829 5,417,464
11 Total support Add lines 7 through 10. 1,435,476,797
12
12
160,341,605
13
First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................right arrow
Section C. Computation of Public Support Percentage
14
14
83.340 %
15
15
84.500 %
16a
b
17a
b
18
Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow
Schedule A (Form 990 or 990-EZ) 2014
Schedule A (Form 990 or 990-EZ) 2014
Page 3
Part III
Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2010 (b) 2011 (c) 2012 (d) 2013 (e) 2014 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......            
3 Gross receipts from activities that are not an unrelated trade or business under section 513..            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge..            
6 Total. Add lines 1 through 5.            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons...            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public support (Subtract line 7c from line 6.)  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2010 (b) 2011 (c) 2012 (d) 2013 (e) 2014 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..            
13 Total support. (Add lines 9, 10c, 11, and 12.)..            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2014
Schedule A (Form 990 or 990-EZ) 2014
Page 4
Part IV
Supporting Organizations
(Complete only if you checked a box on line 11 of Part I. If you checked 11a of Part I, complete Sections A and B. If you checked 11b of Part I, complete Sections A and C. If you checked 11c of Part I, complete Sections A, D, and E. If you checked 11d of Part I, complete Sections A and D, and complete Part V.)
Section A. All Supporting Organizations
Yes
No
1
Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.
1
 
 
2
Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).
2
 
 
3a
Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer (b) and (c) below.
3a
 
 
b
Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.
3b
 
 
c
Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.
3c
 
 
4a
Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked 11a or 11b in Part I, answer (b) and (c) below.
4a
 
 
b
Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations....
4b
 
 
c
Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.
4c
 
 
5a
Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer (b) and (c) below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed, (ii) the reasons for each such action, (iii) the authority under the organization's organizing document authorizing such action, and (iv) how the action was accomplished (such as by amendment to the organizing document).
5a
 
 
b
Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?
5b
 
 
c
Substitutions only. Was the substitution the result of an event beyond the organization's control?
5c
 
 
6
Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (a) its supported organizations; (b) individuals that are part of the charitable class benefited by one or more of its supported organizations; or (c) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.
6
 
 
7
Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in IRC 4958(c)(3)(C)), a family member of a substantial contributor, or a 35-percent controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990) .
7
 
 
8
Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part II of Schedule L (Form 990).
8
 
 
9a
Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.
9a
 
 
b
Did one or more disqualified persons (as defined in line 9(a)) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.
9b
 
 
c
Did a disqualified person (as defined in line 9(a)) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.
9c
 
 
10a
Was the organization subject to the excess business holdings rules of IRC 4943 because of IRC 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer b below.
10a
 
 
b
Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).
10b
 
 
11
Has the organization accepted a gift or contribution from any of the following persons?
a
A person who directly or indirectly controls, either alone or together with persons described in (b) and (c) below, the governing body of a supported organization?
11a
 
 
b
A family member of a person described in (a) above?
11b
 
 
c
A 35% controlled entity of a person described in (a) or (b) above? If “Yes” to a, b, or c, provide detail in Part VI.
11c
 
 
Schedule A (Form 990 or 990-EZ) 2014
Schedule A (Form 990 or 990-EZ) 2014
Page 5
Part IV
Supporting Organizations (continued)

Section B. Type I Supporting Organizations
Yes
No
1
Did the directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.
1
 
 
2
Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.
2
 
 
Section C. Type II Supporting Organizations
Yes
No
1
Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).
1
 
 
Section D. All Type III Supporting Organizations
Yes
No
1
Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (1) a written notice describing the type and amount of support provided during the prior tax year, (2) a copy of the Form 990 that was most recently filed as of the date of notification, and (3) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?
1
 
 
2
Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).
2
 
 
3
By reason of the relationship described in (2), did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.
3
 
 
Section E. Type III Functionally-Integrated Supporting Organizations
1
Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):
a
b
c
2
Activities Test. Answer (a) and (b) below.
Yes
No
a
Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.
2a
 
 
b
Did the activities described in (a) constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.
2b
 
 
3
Parent of Supported Organizations. Answer (a) and (b) below.
a
Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations? Provide details in Part VI.
3a
 
 
b
Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI the role played by the organization in this regard.
3b
 
 
Schedule A (Form 990 or 990-EZ) 2014
Schedule A (Form 990 or 990-EZ) 2014
Page 6
Part V – Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations

1.   Check here if the organization satisfied the Integral Part Test as a qualifying trust on Nov. 20, 1970. See instructions. All other Type III non-functionally integrated supporting organizations must complete Sections A through E.
Section A - Adjusted Net Income (A) Prior Year (B) Current Year
(optional)
1 Net short-term capital gain 1    
2 Recoveries of prior-year distributions 2    
3 Other gross income (see instructions) 3    
4 Add lines 1 through 3 4    
5 Depreciation and depletion 5    
6 Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) 6    
7 Other expenses (see instructions) 7    
8 Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) 8    

Section B - Minimum Asset Amount (A) Prior Year (B) Current Year
(optional)
1 Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): 1
a Average monthly value of securities 1a    
b Average monthly cash balances 1b    
c Fair market value of other non-exempt-use assets 1c    
d Total (add lines 1a, 1b, and 1c) 1d    
e Discount claimed for blockage or other factors (explain in detail in Part VI):  
2 Acquisition indebtedness applicable to non-exempt use assets 2    
3 Subtract line 2 from line 1d 3    
4 Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). 4    
5 Net value of non-exempt-use assets (subtract line 4 from line 3) 5    
6 Multiply line 5 by .035 6    
7 Recoveries of prior-year distributions 7    
8 Minimum Asset Amount (add line 7 to line 6) 8    

Section C - Distributable Amount Current Year
1 Adjusted net income for prior year (from Section A, line 8, Column A) 1  
2 Enter 85% of line 1 2  
3 Minimum asset amount for prior year (from Section B, line 8, Column A) 3  
4 Enter greater of line 2 or line 3 4  
5 Income tax imposed in prior year 5  
6 Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) 6  
7   Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions)
Schedule A (Form 990 or 990-EZ) 2014
Schedule A (Form 990 or 990-EZ) 2014
Page 7
Section D - Distributions Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes  
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in
excess of income from activity		  
3 Administrative expenses paid to accomplish exempt purposes of supported organizations  
4 Amounts paid to acquire exempt-use assets  
5 Qualified set-aside amounts (prior IRS approval required)  
6 Other distributions (describe in Part VI). See instructions  
7Total annual distributions. Add lines 1 through 6.  
8 Distributions to attentive supported organizations to which the organization is responsive (provide
details in Part VI). See instructions		  
9 Distributable amount for 2014 from Section C, line 6  
10 Line 8 amount divided by Line 9 amount  

Section E - Distribution Allocations (see instructions) (i)
Excess Distributions 		(ii)
Underdistributions
Pre-2014 		(iii)
Distributable
Amount for 2014
1 Distributable amount for 2014 from Section C, line
6 		 
2 Underdistributions, if any, for years prior to 2014
(reasonable cause required--see instructions)		  
3 Excess distributions carryover, if any, to 2014:
a From 2009.......X
b From 2010.......X
c From 2011.......X
d From 2012.......X
e From 2013.......  
fTotal of lines 3a through e  
g Applied to underdistributions of prior years  
h Applied to 2014 distributable amount  
i Carryover from 2009 not applied (see
instructions)
j Remainder. Subtract lines 3g, 3h, and 3i from 3f.  
4Distributions for 2014 from Section D, line 7:
$  
a Applied to underdistributions of prior years  
b Applied to 2014 distributable amount  
c Remainder. Subtract lines 4a and 4b from 4.  
5 Remaining underdistributions for years prior to
2014, if any. Subtract lines 3g and 4a from line 2
(if amount greater than zero, see instructions)		  
6 Remaining underdistributions for 2014. Subtract
lines 3h and 4b from line 1 (if amount greater than
zero, see instructions)		  
7 Excess distributions carryover to 2015. Add lines
3j and 4c.		  
8 Breakdown of line 7:
a From 2010.......X
b From 2011.......X
c From 2012.......X
d From 2013.......  
e From 2014.......  
Schedule A (Form 990 or 990-EZ) (2014)
Schedule A (Form 990 or 990-EZ) 2014
Page 8
Part VI
Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Return Reference Explanation
PART II, LINE 10 GRANT TERMINATIONS & REFUNDS 5,069,350 OTHER MISC. REVENUE 348,114
Schedule A (Form 990 or 990-EZ) 2014

Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors
Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
Arrow Bullet Information about Schedule B (Form 990, 990-EZ, or 990-PF) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ





Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......... Arrow Bullet $  
Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2014)

Schedule B (Form 990, 990-EZ, or 990-PF) (2014)
Page 2
Name of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
  		Employer identification number

13-5644916
Part I
Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
RESTRICTED
 
 

   
 
 
  ,    

$RESTRICTED


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2014)

Schedule B (Form 990, 990-EZ, or 990-PF) (2014)
Page 3
Name of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
  		Employer identification number

13-5644916
Part II
Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2014)

Schedule B (Form 990, 990-EZ, or 990-PF) (2014)
Page 4
Name of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
  		Employer identification number

13-5644916
Part III
Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10)
that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet$  
Use duplicate copies of Part III if additional space is needed.
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2014)

Additional Data


Software ID:  
Software Version:  
SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527
SchCMd Bullet Complete if the organization is described below.SchCMd Bullet Attach to Form 990 or Form 990-EZ.
SchCMd Bullet Information about Schedule C (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public
Inspection
If the organization answered "Yes" to Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" to Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" to Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet Section 501(c)(4), (5), or (6) organizations: Complete Part III.
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I-A
Complete if the organization is exempt under section 501(c) or is a section 527 organization.

1
Provide a description of the organization’s direct and indirect political campaign activities in Part IV.
2
Political expenditures ....................................SchCMd Bullet
$  
3
Volunteer hours ........................................
 

Part I-B
Complete if the organization is exempt under section 501(c)(3).
1
Enter the amount of any excise tax incurred by the organization under section 4955 .........SchCMd Bullet
$  
2
Enter the amount of any excise tax incurred by organization managers under section 4955 ......SchCMd Bullet
$  
3
If the organization incurred a section 4955 tax, did it file Form 4720 for this year? ..............
4a
Was a correction made? .........................................
b
If "Yes," describe in Part IV.
Part I-C
Complete if the organization is exempt under section 501(c), except section 501(c)(3).
1
Enter the amount directly expended by the filing organization for section 527 exempt function activities SchCMd Bullet
$  
2
Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ...................................SchCMd Bullet

$  
3
Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b..SchCMd Bullet

$  
4
Did the filing organization file Form 1120-POL for this year? ..........................
5
Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.
(a) Name (b) Address (c) EIN (d) Amount paid from filing organization's funds. If none, enter -0-. (e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.










For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.
Cat. No. 50084S
Schedule C (Form 990 or 990-EZ) 2014

Schedule C (Form 990 or 990-EZ) 2014
Page 2
Part II-A
Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).
A Check SchCMd Bulletexpenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet
Limits on Lobbying Expenditures
(The term "expenditures" means amounts paid or incurred.) 		(a) Filing
organization's
totals 		(b) Affiliated group
totals
1a Total lobbying expenditures to influence public opinion (grass roots lobbying) ......    
b Total lobbying expenditures to influence a legislative body (direct lobbying) .......    
c Total lobbying expenditures (add lines 1a and 1b) ...................    
d Other exempt purpose expenditures ........................    
e Total exempt purpose expenditures (add lines 1c and 1d) ...............    
f Lobbying nontaxable amount. Enter the amount from the following table in both
columns.		    
If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
Not over $500,00020% of the amount on line 1e.
Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
Over $17,000,000$1,000,000.
g Grassroots nontaxable amount (enter 25% of line 1f) .................    
h Subtract line 1g from line 1a. If zero or less, enter -0-. ................    
i Subtract line 1f from line 1c. If zero or less, enter -0-. ................    
j If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting
section 4911 tax for this year? ......................................

4-Year Averaging Period Under section 501(h)
(Some organizations that made a section 501(h) election do not have to complete all of the five
columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
Calendar year (or fiscal year
beginning in) 		(a) 2011 (b) 2012 (c) 2013 (d) 2014 (e) Total
2a Lobbying nontaxable amount          
b Lobbying ceiling amount
(150% of line 2a, column(e)) 		 
c Total lobbying expenditures          
d Grassroots nontaxable amount          
e Grassroots ceiling amount
(150% of line 2d, column (e))		  
f Grassroots lobbying expenditures          
Schedule C (Form 990 or 990-EZ) 2014


Schedule C (Form 990 or 990-EZ) 2014
Page 3
Part II-B
Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).
For each "Yes" response to lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.
(a)
No
Yes
(b)
Amount
1
During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:
a
Volunteers? .........................................
Yes
 
b
Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ....
Yes
 
c
Media advertisements? ....................................
 
No
 
d
Mailings to members, legislators, or the public? .........................
 
No
 
e
Publications, or published or broadcast statements? .......................
Yes
 
149,762
f
Grants to other organizations for lobbying purposes? .......................
 
No
 
g
Direct contact with legislators, their staffs, government officials, or a legislative body? ........
Yes
 
164,749
h
Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ......
Yes
 
236,088
i
Other activities? ..........................
Yes
 
623,467
j
Total. Add lines 1c through 1i ...............................
1,174,066
2a
Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....
 
No
b
If "Yes," enter the amount of any tax incurred under section 4912 .................
 
c
If "Yes," enter the amount of any tax incurred by organization managers under section 4912 .....
 
d
If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? .......
 
 
Part III-A
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).
Yes
No
1
Were substantially all (90% or more) dues received nondeductible by members? ................
1
 
 
2
Did the organization make only in-house lobbying expenditures of $2,000 or less? ................
2
 
 
3
Did the organization agree to carry over lobbying and political expenditures from the prior year? ..........
3
 
 
Part III-B
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."
1
Dues, assessments and similar amounts from members .....................
1
 
2
Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political
expenses for which the section 527(f) tax was paid).
a
Current year .........................................
2a
 
b
Carryover from last year ....................................
2b
 
c
Total ............................................
2c
 
3
Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .
3
 
4
If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ................................
4
 
5
Taxable amount of lobbying and political expenditures (see instructions) ..............
5
 
Part IV
Supplemental Information
Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.
Return Reference Explanation
SCHEDULE C, PART II-B, LINE 1 LLS IS A MEMBER OF A NUMBER OF COALITIONS AND MEMBERSHIPS INCLUDING FRIENDS OF CANCER RESEARCH, ALLIANCE FOR A STRONGER FDA, ONE VOICE AGAINST CANCER, NATIONAL HEALTH COUNCIL, THE CANCER LEADERSHIP COUNCIL AND THE STATE ACCESS TO INNOVATIVE MEDICINES COALITION. LLS PARTNERS WITH A NUMBER OF LOBBYING FIRMS WHO WORK WITH OUR PUBLIC POLICY STAFF TO CARRY OUT OUR LOBBYING OBJECTIVES. LLS MOBILIZES PATIENT-ADVOCATES AND VOLUNTEERS TO ENGAGE WITH THEIR FEDERAL AND STATE LEGISLATORS THROUGH DIGITAL ADVOCACY - SENDING LETTERS; SHARING THEIR PERSONAL STORIES; SIGNING PETITIONS; AND ENCOURAGING THEIR LEGISLATORS TO SUPPORT LLS' POLICY PRIORITIES. IN CONJUNCTION WITH LLS EMPLOYEES, PATIENT-ADVOCATES ALSO VISIT THEIR LEGISLATORS IN THEIR LOCAL OFFICES, IN WASHINGTON, DC AND IN STATE CAPITOLS TO FURTHER LLS' POLICY AGENDA.
Schedule C (Form 990 or 990EZ) 2014

Additional Data


Software ID:  
Software Version:  

SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet Attach to Form 990.
Information about Schedule D (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .........    
2 Aggregate value of contributions to (during year)    
3 Aggregate value of grants from (during year)    
4 Aggregate value at end of year ........    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ....................... 2a  
b Total acreage restricted by conservation easements .................. 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register .................... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................
6
Staff and volunteer hours devoted to monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .......................................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenue included in Form 990, Part VIII, line 1 ........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ..............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:
a
Revenue included in Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2014

Schedule D (Form 990) 2014
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b
If "Yes," explain the arrangement in Part XIII and complete the following table:
Amount
c Beginning balance ................................. 1c  
d Additions during the year .............................. 1d  
e Distributions during the year ............................. 1e  
f Ending balance ................................... 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability?
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII .......
Part V
Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.
(a)Current year (b)Prior year b (c)Two years back (d)Three years back (e)Four years back
1a Beginning of year balance .... 6,122,698 6,027,657 6,000,186 6,059,994 5,023,902
b Contributions ........         111,064
c Net investment earnings, gains, and losses 218,549 313,872 482,520 48,916 938,068
d Grants or scholarships ..... -221,499 -215,000 -450,000    
e Other expenditures for facilities
and programs ........ 		         
f Administrative expenses .... -4,103 -3,831 -5,049 -9,992 -13,040
g End of year balance ...... 6,115,645 6,122,698 6,027,657 6,000,186 6,059,994
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment SchDMd Bullet  
b
Permanent endowment SchDMd Bullet50.000 %
c
Temporarily restricted endowment SchDMd Bullet50.000 %
The percentages in lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) unrelated organizations ........................
3a(i)
 
No
(ii) related organizations ........................
3a(ii)
 
No
b
If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis (investment) (b)Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .................      
b Buildings ................        
c Leasehold improvements ............   942,329 504,716 437,613
d Equipment ................   31,500,031 17,235,878 14,264,153
e Other .................   2,690,600 2,689,855 745
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......SchDMdBullet 14,702,511
Schedule D (Form 990) 2014

Schedule D (Form 990) 2014
Page 3
Part VII
Investments—Other Securities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b)Book value (c) Method of valuation:
Cost or end-of-year market value
(1)Financial derivatives    
(2)Closely-held equity interests    
(3)Other
(A) FUND OF HEDGE FUNDS- OPERATING 		46,036,786 F

(B) 457B PLAN 		1,491,954 F

(C) FUND OF HEDGE FUNDS-ENDOWMENT 		1,424,511 F






Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet 48,953,251
Part VIII
Investments—Program Related. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value








Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value








Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
Federal income taxes  








Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet  
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII
Schedule D (Form 990) 2014

Schedule D (Form 990) 2014
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1 298,163,084
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains (losses) on investments .... 2a -3,934,019
b Donated services and use of facilities ......... 2b 9,864,376
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ............ 2d 10,678,994
e Add lines 2a through 2d ..................... 2e 16,609,351
3 Subtract line 2e from line 1..................... 3 281,553,733
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a 75,197
b Other (Describe in Part XIII.) ........... 4b  
c Add lines 4a and 4b....................... 4c 75,197
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5 281,628,930
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1 297,885,296
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities .......... 2a 9,864,376
b Prior year adjustments .............. 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ............ 2d 10,653,060
e Add lines 2a through 2d...................... 2e 20,517,436
3 Subtract line 2e from line 1..................... 3 277,367,860
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a 75,197
b Other (Describe in Part XIII.) ............ 4b  
c Add lines 4a and 4b....................... 4c 75,197
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5 277,443,057
Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
SCHEDULE D, PAGE 2, PART III, LINE 4 THE LLS COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT LLS'S PROGRAMS.
SCHEDULE D, PAGE 2, PART V, LINE 4 LLS'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT LLS'S PUBLIC EDUCATION PROGRAMS.
SCHEDULE D, PAGE 3, PART X LLS RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE TAX POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO LLS'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. LLS DID NOT RECOGNIZE ANY UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED JUNE 30, 2015 AND 2014.
SCHEDULE D, PAGE 4, PART XI, LINE 2D LLS CANADA REVENUE 10,501,177 LLS CANADA GAIN ON INVESTMENT 177,817
SCHEDULE D, PAGE 4, PART XII, LINE 2D LLS CANADA EXPENSES 10,122,744 FOREIGN CURRENCY TRANSLATION 530,316
Schedule D (Form 990) 2014

Additional Data


Software ID:  
Software Version:  




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990.Right pointing arrow large image Information about Schedule F (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants
and other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria
used to award the grants or assistance? ...........................
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in region (d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in region		 (f) Total expenditures
for and investments
in region
EAST ASIA   3 RESEARCH FUNDING RESEARCH GRANTS 1,695,000
EUROPE   13 RESEARCH FUNDING RESEARCH GRANTS 4,351,803
NORTH AMERICA 7 6 RESEARCH FUNDING RESEARCH GRANTS 1,662,758
CENTRAL AMERICA & CARIBBEAN     INVESTMENTS INVESTMENTS 20,635,431
           
           
           
           
           
           
           
           
           
           
           
           
           
3a Sub-total ..... 7 22 28,344,992
b Total from continuation sheets to Part I ...      
c Totals (add lines 3a and 3b) 7 22 28,344,992
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2014
Schedule F (Form 990) 2014
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (a)(c) Region (b)(d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of non-cash
assistance 		(h) Description
of non-cash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
EAST ASIA & PACIFIC RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EAST ASIA & PACIFIC RESEARCH GRANT 55,000 CHECK     ACCRUAL
EAST ASIA & PACIFIC RESEARCH GRANT 390,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 65,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 110,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 395,665 CHECK     ACCRUAL
EUROPE THERAPY ACCELERATION 1,000,000 WIRE     FMV
EUROPE THERAPY ACCELERATION 750,000 WIRE     FMV
EUROPE THERAPY ACCELERATION 16,138 CHECK     FMV
EUROPE THERAPY ACCELERATION 10,000 CHECK     FMV
EUROPE THERAPY ACCELERATION 100,000 CHECK     FMV
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 300,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 363,353 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 399,405 CHECK     ACCRUAL
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter ....MediumBullet
 
3
Enter total number of other organizations or entities .......................MediumBullet
18
Schedule F (Form 990) 2014
Schedule F (Form 990) 2014Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
non-cash
assistance 		(g) Description
of non-cash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2014
Schedule F (Form 990) 2014
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926)......................................
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; do not file with Form 990)............................
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471)..............................
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621)...............................................
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865)....................................
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see Instructions for Form 5713; do not file with Form 990).....................................
Schedule F (Form 990) 2014
Schedule F (Form 990) 2014
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).
ReturnReference Explanation
SCHEDULE F, PAGE 1, PART I, LINE 2 FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT.
SCHEDULE F, PAGE 1, PART I, LINE 3 EAST ASIA 1,695,000 0 EUROPE 4,351,803 0 NORTH AMERICA 1,662,758 0 CENTRAL AMERICA & CARIBBEAN 0 20,635,431
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2014
Additional Data


Software ID:  
Software Version:  



SCHEDULE G (Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Supplemental Information Regarding
Fundraising or Gaming Activities
Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. right arrowAttach to Form 990 or Form 990-EZ.
right arrowInformation about Schedule G (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17. Form 990-EZ
filers are not required to complete this part.
1
Indicate whether the organization raised funds through any of the following activities. Check all that apply.
a e
b f
c g
d
2a
Did the organization have a written or oral agreement with any individual (including officers, directors, trustees
or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?
b
If "Yes," list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.
(i) Name and address of individual
or entity (fundraiser) 		(ii) Activity (iii) Did fundraiser have custody or control of contributions? (iv) Gross receipts
from activity 		(v) Amount paid to
(or retained by)
fundraiser listed in
col. (i) 		(vi) Amount paid to
(or retained by)
organization
Yes No
 
MAIL AMERICA COMMUNICATIONS INC
174 ELKTON FARM ROAD
 
FOREST, VA24551 		DIRECT MAI   No   5,000,715 -5,000,715
 
INFOCISION MANAGEMENT CORPORATION
325 SPRINSIDE DRIVE
 
AKRON, OH44333 		TELEMARKET   No   828,717 -828,717
 
THOMPSON HABIB & DENISON
80 HAYDEN AVENUE SUITE 300
 
LEXINGTON, MA02421 		DIRECT MAI   No   575,275 -575,275
 
COINSTAR
1800 114TH AVENUE SE
 
BELLEVUE, WA98004 		COIN COLLE   No   400,303 -400,303
 
DONOR CARE CENTER INC
4345 STRAUSSSER ST NW
 
NORTH CANTON, OH44720 		TELEMARKET   No   212,080 -212,080
             
             
             
             
             
Total .................right arrow   7,017,090 -7,017,090
3
List all states in which the organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing.
All States
For Paperwork Reduction Act Notice, see the Instructions for Form 990or 990-EZ.
Cat. No. 50083H
Schedule G (Form 990 or 990-EZ) 2014
Schedule G (Form 990 or 990-EZ) 2014
Page 2
Part II
Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.
(a) Event #1

NIKE WOMEN MARA
(event type) 		(b) Event #2

LAKE TAHOE CYCL
(event type) 		(c) Other events

741
(total number) 		(d) Total events
(add col. (a) through col. (c))
VerticalRevenue 1 Gross receipts . . . 4,507,326 3,308,624 170,178,221 177,994,171
2 Less: Contributions . . 4,476,491 3,294,124 154,425,786 162,196,401
3 Gross income (line 1
minus line 2) . . . 		30,835 14,500 15,752,435 15,797,770
VerticalDirectExpenses 4 Cash prizes . . .        
5 Noncash prizes . . 8,829 63,659 3,806,128 3,878,616
6 Rent/facility costs . . 556,046 190,171 7,237,129 7,983,346
7 Food and beverages . 77,427 31,311 3,240,623 3,349,361
8 Entertainment . . .     1,083,633 1,083,633
9 Other direct expenses . 547,023 261,890 6,453,575 7,262,488
10 Direct expense summary. Add lines 4 through 9 in column (d) ........... right arrow 23,557,444
11 Net income summary. Subtract line 10 from line 3, column (d)........... right arrow -7,759,674
Part III
Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.
VerticalRevenue (a) Bingo (b) Pull tabs/Instant
bingo/progressive bingo 		(c) Other gaming (d) Total gaming (add col.(a) through col.(c))
1 Gross revenue . . . .     631,918 631,918
VerticalDirectExpenses 2 Cash prizes . . . .     3,913 3,913
3 Non-cash prizes . . .     129,490 129,490
4 Rent/facility costs . . .        
5 Other direct expenses . .     4,000 4,000
6 Volunteer labor . . .
%
%
90.000 %
7 Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow 137,403
8 Net gaming income summary. Subtract line 7 from line 1, column (d) ......... right arrow 494,515
9
Enter the state(s) in which the organization conducts gaming activities:
a
Is the organization licensed to conduct gaming activities in each of these states? ............
b
If "No," explain:
 
10a
Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....
b
If "Yes," explain:
 
Schedule G (Form 990 or 990-EZ) 2014
Schedule G (Form 990 or 990-EZ) 2014
Page 3
11
Does the organization conduct gaming activities with nonmembers? .................
12
Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity
formed to administer charitable gaming? ..........................
13
Indicate the percentage of gaming activities conducted in:
a
The organization's facility ......................
13a
25.000 %
b
An outside facility ........................
13b
75.000 %
14
Enter the name and address of the person who prepares the organization's gaming/special events books and records:
Name right arrow
ROSEMARIE LOFFREDO
Address right arrow
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
15a
Does the organization have a contract with a third party from whom the organization receives gaming
revenue? ......................................
b
If "Yes," enter the amount of gaming revenue received by the organization right arrow $   and the
amount of gaming revenue retained by the third party right arrow $  
c
If "Yes," enter name and address of the third party:
Name right arrow
Address right arrow
 
 
16
Gaming manager information:
Name right arrow
SEE SCHEDULE G PART IV
Gaming manager compensation right arrow $  
Description of services provided right arrow
 
17
Mandatory distributions:
a
Is the organization required under state law to make charitable distributions from the gaming proceeds to
retain the state gaming license? ............................
b
Enter the amount of distributions required under state law distributed to other exempt organizations or spent
in the organization's own exempt activities during the tax year right arrow$  
Part IV
Supplemental Information. Provide the explanations required by Part I, line 2b, columns (iii) and (v), and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also provide any additional information (see instructions).
Return Reference Explanation
SCHEDULE G, PART IV SCHEDULE G PART I, LINE 2B LLS USED MAIL AMERICA COMMUNICATIONS AND THOMPSON, HABIB & DENISON FOR ITS NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMS. THESE PROGRAMS GENERATED GROSS RECEIPTS OF 20,336,576 DURING FISCAL YEAR 2015. LLS USED INFOCISION MANAGEMENT CORPORATION, COINSTAR AND DONOR CARE CENTER FOR ALL OF ITS OTHER FUNDRAISING EVENTS DURING FISCAL YEAR 2015. SCHEDULE G, PART II - LINE 2 CONTRIBUTIONS REPRESENT THE CASH DONATIONS IN EXCESS OF THE FAIR MARKET VALUE OF BENEFITS PROVIDED TO THE DONOR. SCHEDULE G, PART II, LINES 4 - 10 DIRECT EXPENSES ARE COSTS INCURRED BY THE ORGANIZATION TO HOST THE EVENTS. SCHEDULE G, PART III, LINE 9 - STATES WITH GAMING OPERATIONS ARIZONA, DISTRICT OF COLUMBIA, IOWA, KANSAS, LOUISIANA, MICHIGAN, NEVADA, NEW YORK, OHIO, OREGON, PENNSYLVANIA, RHODE ISLAND, TEXAS, WISCONSIN. SCHEDULE G, PART III, LINE 16 THE LEUKEMIA & LYMPHOMA SOCIETY DOES NOT HAVE AN OVERALL MANAGER FOR GAMING ACTIVITIES. EACH GAMING EVENT IS MANAGED LOCALLY BY THE SPECIFIC CHAPTER STAFF.
Schedule G (Form 990 or 990-EZ) 2014
Additional Data


Software ID:  
Software Version:  
Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990.
lBullet Information about Schedule I (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number
13-5644916
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21, for any recipient that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC section
if applicable		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
non-cash assistance		 (h) Purpose of grant
or assistance
(1) ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRSIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(2) ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRSIS PARK AVE
BRONX,NY10461 		13-1624225 3 110,000   ACCRUAL   RESEARCH GRANT
(3) ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRSIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(4) ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRSIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(5) ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRSIS PARK AVE
BRONX,NY10461 		13-1624225 3 110,000   ACCRUAL   RESEARCH GRANT
(6) ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRSIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(7) BAYLOR COLLEGE OF MEDICINE
1 BAYLOR PLAZA
HOUSTON,TX77030 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(8) BAYLOR COLLEGE OF MEDICINE
1 BAYLOR PLAZA
HOUSTON,TX77031 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(9) BAYLOR COLLEGE OF MEDICINE
1 BAYLOR PLAZA
HOUSTON,TX77032 		74-1613878 3 1,250,000   ACCRUAL   RESEARCH GRANT
(10) BAYLOR COLLEGE OF MEDICINE
1 BAYLOR PLAZA
HOUSTON,TX77033 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(11) BECKMAN RESEARCH INSTITUTE OF CITY
1500 DUARTE ROAD
DUARTE,CA910103000 		95-3432210 3 400,000   ACCRUAL   RESEARCH GRANT
(12) BECKMAN RESEARCH INSTITUTE OF THE C
1500 DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(13) BECKMAN RESEARCH INSTITUTE OF THE C
1500 DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(14) BETH ISRAEL DEACONESS MEDICAL CENTE
330 BROOKLINE AVENUE
BOSTON,MA02215 		04-2103881 3 200,000   ACCRUAL   RESEARCH GRANT
(15) BETH ISRAEL DEACONESS MEDICAL CENTE
330 BROOKLINE AVENUE
BOSTON,MA02215 		04-2103881 3 55,000   ACCRUAL   RESEARCH GRANT
(16) BETH ISRAEL DEACONESS MEDICAL CENTE
330 BROOKLINE AVENUE
BOSTON,MA02215 		04-2103881 3 110,000   ACCRUAL   RESEARCH GRANT
(17) BRANDEIS UNIVERSITY
415 SOUTH STREET
WALTHAM,MA02453 		04-2103552 3 55,000   ACCRUAL   RESEARCH GRANT
(18) BRIGHAM & WOMENS HOSPITAL
75 FRANCIS STREET
BOSTON,MA02115 		04-2312909 3 1,250,000   ACCRUAL   RESEARCH GRANT
(19) BRIGHAM & WOMENS HOSPITAL
75 FRANCIS STREET
BOSTON,MA02115 		04-2312909 3 200,000   ACCRUAL   RESEARCH GRANT
(20) BRIGHAM & WOMENS HOSPITAL
75 FRANCIS STREET
BOSTON,MA02115 		04-2312909 3 110,000   ACCRUAL   RESEARCH GRANT
(21) BRIGHAM & WOMENS HOSPITAL
75 FRANCIS STREET
BOSTON,MA02115 		04-2312909 3 110,000   ACCRUAL   RESEARCH GRANT
(22) BRIGHAM & WOMENS HOSPITAL
75 FRANCIS STREET
BOSTON,MA02115 		04-2312909 3 55,000   ACCRUAL   RESEARCH GRANT
(23) CALIFORNIA INSTITUTE OF TECHNOLOGY
12200 E CALIFORNIA BLVD
PASADENA,CA91125 		95-1643307 3 55,000   ACCRUAL   RESEARCH GRANT
(24) CALIFORNIA INSTITUTE OF TECHNOLOGY
12200 E CALIFORNIA BLVD
PASADENA,CA91125 		95-1643307 3 55,000   ACCRUAL   RESEARCH GRANT
(25) CASE WESTERN RESERVE UNIVERSITY - S
2109 ADELBERT ROAD
CLEVELAND,OH44106 		34-1018992 3 200,000   ACCRUAL   RESEARCH GRANT
(26) CASE WESTERN RESERVE UNIVERSITY - S
2109 ADELBERT ROAD
CLEVELAND,OH44106 		34-1018992 3 200,000   ACCRUAL   RESEARCH GRANT
(27) CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVD
LOS ANGELES,CA90048 		95-1644600 3 133,333   ACCRUAL   RESEARCH GRANT
(28) CHILDRENS HOSPITAL CORPORATION
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 3 65,000   ACCRUAL   RESEARCH GRANT
(29) CHILDRENS HOSPITAL CORPORATION
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 3 55,000   ACCRUAL   RESEARCH GRANT
(30) CHILDRENS HOSPITAL CORPORATION
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 3 55,000   ACCRUAL   RESEARCH GRANT
(31) CHILDRENS HOSPITAL CORPORATION
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 3 55,000   ACCRUAL   RESEARCH GRANT
(32) CHILDREN'S HOSPITAL OF PHILADELPHIA
CIVIC CENTER BLVD
PHILADELPHIA,PA19104 		23-1352166 3 200,000   ACCRUAL   RESEARCH GRANT
(33) CHILDREN'S HOSPITAL OF PHILADELPHIA
CIVIC CENTER BLVD
PHILADELPHIA,PA19104 		23-1352166 3 110,000   ACCRUAL   RESEARCH GRANT
(34) CINCINNATI CHILDRENS HOSPITAL MEDI
3333 BURNET AVENUE
CINCINATTI,OH45209 		31-0833936 3 110,000   ACCRUAL   RESEARCH GRANT
(35) CINCINNATI CHILDREN'S HOSPITAL MEDI
3333 BURNET AVENUE
CINCINATTI,OH45209 		31-0833936 3 200,000   ACCRUAL   RESEARCH GRANT
(36) CINCINNATI CHILDREN'S HOSPITAL MEDI
3333 BURNET AVENUE
CINCINATTI,OH45209 		31-0833936 3 55,000   ACCRUAL   RESEARCH GRANT
(37) CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUE
CLEVELAND,OH44195 		91-2153073 3 200,000   ACCRUAL   RESEARCH GRANT
(38) COLD SPRING HARBOR LABORATORY
1 BUNGTOWN ROAD
COLD SPRING HARBOR,NY11724 		11-2013303 3 110,000   ACCRUAL   RESEARCH GRANT
(39) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(40) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(41) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(42) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(43) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(44) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(45) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(46) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 110,000   ACCRUAL   RESEARCH GRANT
(47) COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 400,000   ACCRUAL   RESEARCH GRANT
(48) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(49) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(50) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(51) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 1,250,000   ACCRUAL   RESEARCH GRANT
(52) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(53) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 288,909   ACCRUAL   RESEARCH GRANT
(54) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(55) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(56) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(57) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(58) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 136,605   ACCRUAL   RESEARCH GRANT
(59) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(60) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(61) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 15,477   ACCRUAL   RESEARCH GRANT
(62) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(63) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(64) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(65) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(66) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(67) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(68) DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE
BOSTON,MA02215 		04-2263040 3 400,000   ACCRUAL   RESEARCH GRANT
(69) DANA FARBER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 194,425   FMV   THERAPY ACCELERATION
(70) DANA FARBER INSTITUTE
450 BROOKLINE AVE
BOSTON,MA02215 		04-2263040 3 194,425   FMV   THERAPY ACCELERATION
(71) DUKE UNIVERSITY MEDICAL CENTER
134 CHAPEL DRIVE
DURHAM,NC27708 		56-0532129 3 200,000   ACCRUAL   RESEARCH GRANT
(72) DUKE UNIVERSITY MEDICAL CENTER
134 CHAPEL DRIVE
DURHAM,NC27708 		56-0532129 3 200,000   ACCRUAL   RESEARCH GRANT
(73) DUKE UNIVERSITY MEDICAL CENTER
SPONSORED PROGRAMS 324 BLACKWELL S
DURHAM,NC27708 		56-0532129 3 398,985   ACCRUAL   RESEARCH GRANT
(74) EMORY UNIVERSITY
PO BOX 935084
ALTANTA,GA31193 		58-0566256 3 250,000   FMV   THERAPY ACCELERATION
(75) FOX CHASE CANCER CENTER
333 COTTMAN AVENUE
PHILADELPHIA,PA191112434 		23-2003072 3 200,000   ACCRUAL   RESEARCH GRANT
(76) FRED HUTCHINSON CANCER RESEARCH CEN
1100 FAIRVIEW AVENUE NORTH J6-500
SEATTLE,WA981091024 		23-7156071 3 55,000   ACCRUAL   RESEARCH GRANT
(77) FRED HUTCHINSON CANCER RESEARCH CEN
1100 FAIRVIEW AVENUE NORTH J6-500
SEATTLE,WA981091024 		23-7156071 3 55,000   ACCRUAL   RESEARCH GRANT
(78) FRED HUTCHINSON CANCER RESEARCH CEN
1100 FAIRVIEW AVENUE NORTH J6-500
SEATTLE,WA981091024 		23-7156071 3 133,333   ACCRUAL   RESEARCH GRANT
(79) FRED HUTCHINSON CANCER RESEARCH CEN
1100 FAIRVIEW AVENUE NORTH J6-500
SEATTLE,WA981091024 		23-7156071 3 110,000   ACCRUAL   RESEARCH GRANT
(80) FRED HUTCHINSON CANCER RESEARCH CEN
1100 FAIRVIEW AVENUE NORTH J6-500
SEATTLE,WA981091024 		23-7156071 3 200,000   ACCRUAL   RESEARCH GRANT
(81) HARVARD UNIVERSITY
25 SHATTUCK STREET ROOM 509
BOSTON,MA02115 		04-2103580 3 55,000   ACCRUAL   RESEARCH GRANT
(82) HARVARD UNIVERSITY
25 SHATTUCK STREET ROOM 509
BOSTON,MA02115 		04-2103580 3 55,000   ACCRUAL   RESEARCH GRANT
(83) HOSPITAL FOR SPECIAL SURGERY
535 E 70TH STREET
NEW YORK,NY10021 		13-6714749 3 200,000   ACCRUAL   RESEARCH GRANT
(84) IMMUNE DISEASE INSTITUTE (FKA) THE
3 BLACKFAN CIRCLE CLSB 3RD FLOOR
BOSTON,MA02115 		04-2158520 3 1,250,000   ACCRUAL   RESEARCH GRANT
(85) INDIANA UNIVERSITY (INDIANAPOLIS)
980 INDIANA AVENUE LOCKEFIELD 2232
INDIANAPOLIS,IN462022915 		35-6001673 3 110,000   ACCRUAL   RESEARCH GRANT
(86) INDIANA UNIVERSITY-PURDUE UNIVERSIT
980 INDIANA AVENUE LOCKEFIELD 2232
INDIANAPOLIS,IN462022915 		35-6001673 3 133,333   ACCRUAL   RESEARCH GRANT
(87) JOAN & SANFORD I WEILL MEDICAL COL
1300 YORK AVENUE BOX 89
NEW YORK,NY100654805 		13-1623978 3 200,000   ACCRUAL   RESEARCH GRANT
(88) JOAN & SANFORD I WEILL MEDICAL COL
1300 YORK AVENUE BOX 89
NEW YORK,NY100654805 		13-1623978 3 200,000   ACCRUAL   RESEARCH GRANT
(89) JOAN & SANFORD I WEILL MEDICAL COL
1300 YORK AVENUE BOX 89
NEW YORK,NY100654805 		13-1623978 3 200,000   ACCRUAL   RESEARCH GRANT
(90) JOAN & SANFORD I WEILL MEDICAL COL
1300 YORK AVENUE BOX 89
NEW YORK,NY100654805 		13-1623978 3 200,000   ACCRUAL   RESEARCH GRANT
(91) JOAN & SANFORD I WEILL MEDICAL COL
1300 YORK AVENUE BOX 89
NEW YORK,NY100654805 		13-1623978 3 110,000   ACCRUAL   RESEARCH GRANT
(92) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY CENTRAL LO
CHICAGO,IL60693 		52-0595110 3 65,000   ACCRUAL   RESEARCH GRANT
(93) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY CENTRAL LO
CHICAGO,IL60693 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(94) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY CENTRAL LO
CHICAGO,IL60693 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(95) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY CENTRAL LO
CHICAGO,IL60693 		52-0595110 3 55,000   ACCRUAL   RESEARCH GRANT
(96) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY CENTRAL LO
CHICAGO,IL60693 		52-0595110 3 277,750   ACCRUAL   RESEARCH GRANT
(97) LA JOLLA INSTITUTE FOR ALLERGY AND
9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 200,000   ACCRUAL   RESEARCH GRANT
(98) MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREET
BOSTON,MA02114 		04-1564655 3 200,000   ACCRUAL   RESEARCH GRANT
(99) MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREET
BOSTON,MA02114 		04-1564655 3 110,000   ACCRUAL   RESEARCH GRANT
(100) MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREET
BOSTON,MA02114 		04-1564655 3 110,000   ACCRUAL   RESEARCH GRANT
(101) MASSACHUSETTS INSTITUTE OF TECHNOLO
77 MASSACHUSETTS AVENUE
CAMBRIDGE,MA02139 		04-2103594 3 55,000   ACCRUAL   RESEARCH GRANT
(102) MASSCHUSETTS GENERAL HOSPITAL
55 FRUIT STREET
BOSTON,MA02114 		04-1564655 3 356,484   ACCRUAL   RESEARCH GRANT
(103) MAYO CLINIC ARIZONA
13400 EAST SHEA BLVD
SCOTTSDALE,AZ85259 		41-6011702 3 200,000   ACCRUAL   RESEARCH GRANT
(104) MAYO CLINIC ARIZONA
13400 EAST SHEA BLVD
SCOTTSDALE,AZ85259 		41-6011702 3 110,000   ACCRUAL   RESEARCH GRANT
(105) MAYO CLINIC ROCHESTER
200 FIRST STREET SW
ROCHESTER,MN55905 		41-6011702 3 300,000   ACCRUAL   RESEARCH GRANT
(106) MAYO CLINIC ROCHESTER
200 FIRST STREET SW
ROCHESTER,MN55905 		41-6011702 3 110,000   ACCRUAL   RESEARCH GRANT
(107) MAYO CLINIC ROCHESTER
200 FIRST STREET SW
ROCHESTER,MN55905 		41-6011702 3 320,258   ACCRUAL   RESEARCH GRANT
(108) MEMORIAL SLOAN-KETTERING CANCER CEN
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 65,000   ACCRUAL   RESEARCH GRANT
(109) MOFFITT CANCER CENTER AND RESEARCH
12902 MAGNOLIA DRIVE
TAMPA,FL33612 		59-3238636 3 200,000   ACCRUAL   RESEARCH GRANT
(110) MOFFITT CANCER CENTER AND RESEARCH
12902 MAGNOLIA DRIVE
TAMPA,FL33612 		59-3238636 3 65,000   ACCRUAL   RESEARCH GRANT
(111) MOUNT SINAI SCHOOL OF MEDICINE
ICAHN SCHOOL OF MEDICINE AT MOUNT S
NEW YORK,NY100296574 		13-6171197 3 110,000   ACCRUAL   RESEARCH GRANT
(112) MOUNT SINAI SCHOOL OF MEDICINE
ICAHN SCHOOL OF MEDICINE AT MOUNT S
NEW YORK,NY100296574 		13-6171197 3 110,000   ACCRUAL   RESEARCH GRANT
(113) NEW YORK UNIVERSITY SCHOOL OF MEDIC
545 FIRST AVENUE GBH SC1-55
NEW YORK,NY10016 		13-5562308 3 200,000   ACCRUAL   RESEARCH GRANT
(114) NEW YORK UNIVERSITY SCHOOL OF MEDIC
545 FIRST AVENUE GBH SC1-55
NEW YORK,NY10016 		13-5562308 3 1,250,000   ACCRUAL   RESEARCH GRANT
(115) NEW YORK UNIVERSITY SCHOOL OF MEDIC
545 FIRST AVENUE GBH SC1-55
NEW YORK,NY10016 		13-5562308 3 65,000   ACCRUAL   RESEARCH GRANT
(116) NORTHWESTERN UNIVERSITY
ASRSP 633 CLARK ROOM G547
EVANSTON,IL60208 		36-2167817 3 200,000   ACCRUAL   RESEARCH GRANT
(117) NORTHWESTERN UNIVERSITY
ASRSP 633 CLARK ROOM G547
EVANSTON,IL60208 		36-2167817 3 300,000   ACCRUAL   RESEARCH GRANT
(118) NORTHWESTERN UNIVERSITY
ASRSP 633 CLARK ROOM G547
EVANSTON,IL60208 		36-2167817 3 200,000   ACCRUAL   RESEARCH GRANT
(119) NORTHWESTERN UNIVERSITY
ASRSP 633 CLARK ROOM G547
EVANSTON,IL60208 		36-2167817 3 1,250,000   ACCRUAL   RESEARCH GRANT
(120) NORTHWESTERN UNIVERSITY
ASRSP 633 CLARK ROOM G547
EVANSTON,IL60208 		36-2167817 3 133,333   ACCRUAL   RESEARCH GRANT
(121) OHIO STATE UNIVERSITY
1960 KENNY ROAD
COLUMBUS,OH43210 		31-6025986 3 200,000   ACCRUAL   RESEARCH GRANT
(122) OHIO STATE UNIVERSITY
1960 KENNY ROAD
COLUMBUS,OH43210 		31-6025986 3 300,000   ACCRUAL   RESEARCH GRANT
(123) OHIO STATE UNIVERSITY
1960 KENNY ROAD
COLUMBUS,OH43210 		31-6025986 3 110,000   ACCRUAL   RESEARCH GRANT
(124) OHIO STATE UNIVERSITY
1960 KENNY ROAD
COLUMBUS,OH43210 		31-6025986 3 65,000   ACCRUAL   RESEARCH GRANT
(125) OREGON HEALTH & SCIENCE UNIVER
0690 SW BANCROFT ST
PORTLAND,OR97239 		93-1176109 3 1,111,000   FMV   THERAPY ACCELERATION
(126) OREGON HEALTH & SCIENCE UNIVER
0690 SW BANCROFT ST
PORTLAND,OR97239 		93-1176109 3 555,500   FMV   THERAPY ACCELERATION
(127) OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK ROAD MAIL
PORTLAND,OR97239 		93-1176109 3 55,000   ACCRUAL   RESEARCH GRANT
(128) PRESIDENT & FELLOWS OF HARVARD COLL
6TH FLOOR HOLYOKE CENTER 1350 MAS
CAMBRIDGE,MA02138 		04-2103580 3 55,000   ACCRUAL   RESEARCH GRANT
(129) PRESIDENT & FELLOWS OF HARVARD COLL
6TH FLOOR HOLYOKE CENTER 1350 MAS
CAMBRIDGE,MA02138 		04-2103580 3 65,000   ACCRUAL   RESEARCH GRANT
(130) PRESIDENT & FELLOWS OF HARVARD COLL
6TH FLOOR HOLYOKE CENTER 1350 MAS
CAMBRIDGE,MA02138 		04-2103580 3 200,000   ACCRUAL   RESEARCH GRANT
(131) REGENTS OF THE UNIV OF MICHIGAN
BOX 223131
PITTSBURGH,PA15251 		38-6006309 3 157,433   FMV   THERAPY ACCELERATION
(132) REGENTS OF THE UNIV OF MICHIGAN
BOX 223131
PITTSBURGH,PA15251 		38-6006309 3 292,835   FMV   THERAPY ACCELERATION
(133) REGENTS OF THE UNIV OF MICHIGAN
BOX 223131
PITTSBURGH,PA15251 		38-6006309 3 238,915   FMV   THERAPY ACCELERATION
(134) REGENTS OF THE UNIVERSITY OF MINNES
450 MCNAMARA ALUMNI CENTER 200 OAK
MINNEAPOLIS,MN55455 		41-6007513 3 200,000   ACCRUAL   RESEARCH GRANT
(135) RHODE ISLAND HOSPITAL
593 EDDY STREET ALDRICH 3-317
PROVIDENCE,RI02903 		05-0258954 3 65,000   ACCRUAL   RESEARCH GRANT
(136) ROCKEFELLER UNIVERSITY
1230 YORK AVENUE
NEW YORK,NY10021 		13-1624158 3 55,000   ACCRUAL   RESEARCH GRANT
(137) ROCKEFELLER UNIVERSITY
1230 YORK AVENUE
NEW YORK,NY10021 		13-1624158 3 55,000   ACCRUAL   RESEARCH GRANT
(138) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 110,000   ACCRUAL   RESEARCH GRANT
(139) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 200,000   ACCRUAL   RESEARCH GRANT
(140) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 55,000   ACCRUAL   RESEARCH GRANT
(141) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 55,000   ACCRUAL   RESEARCH GRANT
(142) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 110,000   ACCRUAL   RESEARCH GRANT
(143) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 110,000   ACCRUAL   RESEARCH GRANT
(144) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 200,000   ACCRUAL   RESEARCH GRANT
(145) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 55,000   ACCRUAL   RESEARCH GRANT
(146) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 200,000   ACCRUAL   RESEARCH GRANT
(147) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 55,000   ACCRUAL   RESEARCH GRANT
(148) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 110,000   ACCRUAL   RESEARCH GRANT
(149) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 65,000   ACCRUAL   RESEARCH GRANT
(150) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 110,000   ACCRUAL   RESEARCH GRANT
(151) SLOAN-KETTERING INSTITUTE FOR CANCE
PO BOX 26338
NEW YORK,NY10087 		13-1924236 3 110,000   ACCRUAL   RESEARCH GRANT
(152) ST JUDE CHILDREN'S RESEARCH HOSPIT
332 N LAUDERFDALE
MEMPHIS,TN38105 		62-0646012 3 110,000   ACCRUAL   RESEARCH GRANT
(153) STANFORD UNIVERSITY
PO BOX 44253
SAN FRANCISCO,CA94144 		94-1156365 3 108,692   FMV   THERAPY ACCELERATION
(154) STANFORD UNIVERSITY
PO BOX 44253
SAN FRANCISCO,CA94144 		94-1156365 3 333,000   FMV   THERAPY ACCELERATION
(155) STOWERS INSTITUTE FOR MEDICAL RESEA
1000 EAST 50TH STREET
KANSAS CITY,MO64110 		20-2993509 3 55,000   ACCRUAL   RESEARCH GRANT
(156) SUNY UPSTATE MEDICAL UNIVERSITY
4283 WEISKOTTEN HALL 750 EAST ADAM
SYRACUSE,NY13210 		16-6038703 3 110,000   ACCRUAL   RESEARCH GRANT
(157) TEMPLE UNIVERSITY
3307 NORTH BROAD STREET
PHILADELPHIA,PA19140 		23-1365971 3 400,000   ACCRUAL   RESEARCH GRANT
(158) THE BOARD OF REGENTS OF THE UNIVERS
21 N PARK ST SUITE 6401
MADISON,WI537151218 		39-6006492 3 215,000   ACCRUAL   RESEARCH GRANT
(159) THE BOARD OF REGENTS OF THE UNIVERS
21 N PARK ST SUITE 6401
MADISON,WI537151218 		39-6006492 3 110,000   ACCRUAL   RESEARCH GRANT
(160) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 55,000   ACCRUAL   RESEARCH GRANT
(161) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 65,000   ACCRUAL   RESEARCH GRANT
(162) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 65,000   ACCRUAL   RESEARCH GRANT
(163) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 65,000   ACCRUAL   RESEARCH GRANT
(164) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 268,353   ACCRUAL   RESEARCH GRANT
(165) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 55,000   ACCRUAL   RESEARCH GRANT
(166) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 110,000   ACCRUAL   RESEARCH GRANT
(167) THE BOARD OF TRUSTEES OF THE LELAND
3160 PORTER DRIVE SUITE 100
PALO ALTO,CA94304 		94-1156365 3 110,000   ACCRUAL   RESEARCH GRANT
(168) THE CHILDREN'S HOSPITAL BOSTON
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 3 110,000   ACCRUAL   RESEARCH GRANT
(169) THE JOHNS HOPKINS UNIVERSITY SCHOOL
JOHNS HOPKINS UNIVERSITY CENTRAL LO
CHICAGO,IL60693 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(170) THE JOHNS HOPKINS UNIVERSITY SCHOOL
JOHNS HOPKINS UNIVERSITY CENTRAL LO
CHICAGO,IL60693 		52-0595110 3 299,116   ACCRUAL   RESEARCH GRANT
(171) THE REGENTS OF THE UNIVERSITY OF CA
2150 SHATTUCK AVENUE SUITE 313
BERKELEY,CA947045940 		94-6002123 3 65,000   ACCRUAL   RESEARCH GRANT
(172) THE REGENTS OF THE UNIVERSITY OF CA
11000 KINROSS AVENUE SUITE 102
LOS ANGELES,CA90095 		95-6006143 3 110,000   ACCRUAL   RESEARCH GRANT
(173) THE REGENTS OF THE UNIVERSITY OF CA
11000 KINROSS AVENUE SUITE 102
LOS ANGELES,CA90095 		95-6006143 3 200,000   ACCRUAL   RESEARCH GRANT
(174) THE REGENTS OF THE UNIVERSITY OF CA
9500 GILMAN DRIVE MC 0009
LA JOLLA,CA920930009 		95-6006144 3 55,000   ACCRUAL   RESEARCH GRANT
(175) THE REGENTS OF THE UNIVERSITY OF CA
9500 GILMAN DRIVE MC 0009
LA JOLLA,CA920930009 		95-6006144 3 110,000   ACCRUAL   RESEARCH GRANT
(176) THE REGENTS OF THE UNIVERSITY OF CA
9500 GILMAN DRIVE MC 0009
LA JOLLA,CA920930009 		95-6006144 3 1,250,000   ACCRUAL   RESEARCH GRANT
(177) THE REGENTS OF THE UNIVERSITY OF CA
9500 GILMAN DRIVE MC 0009
LA JOLLA,CA920930009 		95-6006144 3 110,000   ACCRUAL   RESEARCH GRANT
(178) THE REGENTS OF THE UNIVERSITY OF CA
9500 GILMAN DRIVE MC 0009
LA JOLLA,CA920930009 		95-6006144 3 110,000   ACCRUAL   RESEARCH GRANT
(179) THE REGENTS OF THE UNIVERSITY OF CA
9500 GILMAN DRIVE MC 0009
LA JOLLA,CA920930009 		95-6006144 3 398,208   ACCRUAL   RESEARCH GRANT
(180) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(181) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(182) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(183) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(184) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(185) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(186) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(187) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 65,000   ACCRUAL   RESEARCH GRANT
(188) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(189) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(190) THE REGENTS OF THE UNIVERSITY OF CA
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(191) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(192) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(193) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(194) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(195) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(196) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(197) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(198) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(199) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 300,000   ACCRUAL   RESEARCH GRANT
(200) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(201) THE REGENTS OF THE UNIVERSITY OF MI
3003 S STATE ST
ANN ARBOR,MI481091274 		38-6006309 3 400,000   ACCRUAL   RESEARCH GRANT
(202) THE SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORREY PINES ROAD TPC-
LA JOLLA,CA92037 		33-0435954 3 55,000   ACCRUAL   RESEARCH GRANT
(203) THE TRUSTEES OF COLUMBIA UNIVERSITY
630 WEST 168TH STREET BOX 49
NEW YORK,NY10032 		13-5598093 3 110,000   ACCRUAL   RESEARCH GRANT
(204) THE TRUSTEES OF THE UNIVERSITY OF P
3451 WALNUT STREET ROOM P-221
PHILADELPHIA,PA191046205 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(205) THE TRUSTEES OF THE UNIVERSITY OF P
3451 WALNUT STREET ROOM P-221
PHILADELPHIA,PA191046205 		23-1352685 3 55,000   ACCRUAL   RESEARCH GRANT
(206) THE UNIVERSITY OF CHICAGO
6030 S ELLIS AVENUE ROOM 114 ED-
CHICAGO,IL60637 		36-2177139 3 200,000   ACCRUAL   RESEARCH GRANT
(207) THE UNIVERSITY OF CHICAGO
6030 S ELLIS AVENUE ROOM 114 ED-
CHICAGO,IL60637 		36-2177139 3 55,000   ACCRUAL   RESEARCH GRANT
(208) THE UNIVERSITY OF NORTH CAROLINA AT
104 AIRPORT DRIVE SUITE 2200 CB 1
CHAPEL HILL,NC275991350 		56-6001393 3 200,000   ACCRUAL   RESEARCH GRANT
(209) THE UNIVERSITY OF NORTH CAROLINA AT
104 AIRPORT DRIVE SUITE 2200 CB 1
CHAPEL HILL,NC275991350 		56-6001393 3 402,524   ACCRUAL   RESEARCH GRANT
(210) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 200,000   ACCRUAL   RESEARCH GRANT
(211) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 110,000   ACCRUAL   RESEARCH GRANT
(212) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 110,000   ACCRUAL   RESEARCH GRANT
(213) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 110,000   ACCRUAL   RESEARCH GRANT
(214) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 110,000   ACCRUAL   RESEARCH GRANT
(215) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 200,000   ACCRUAL   RESEARCH GRANT
(216) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 200,000   ACCRUAL   RESEARCH GRANT
(217) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 200,000   ACCRUAL   RESEARCH GRANT
(218) THE UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 904
HOUSTON,TX77030 		74-6001118 3 400,000   ACCRUAL   RESEARCH GRANT
(219) UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE SOUTH SUITE 1170 AB
BIRMINGHAM,AL352940111 		63-6005396 3 300,000   ACCRUAL   RESEARCH GRANT
(220) UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE SOUTH SUITE 1170 AB
BIRMINGHAM,AL352940111 		63-6005396 3 110,000   ACCRUAL   RESEARCH GRANT
(221) UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE MC 0009
LA JOLLA,CA920930009 		95-2872494 3 55,000   ACCRUAL   RESEARCH GRANT
(222) UNIVERSITY OF CALIFORNIA SAN FRANC
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(223) UNIVERSITY OF CALIFORNIA SAN FRANC
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(224) UNIVERSITY OF CALIFORNIA SAN FRANC
3333 CALIFRORNIA ST SUITE 315
SAN FRANCISCO,CA941430962 		94-6036493 3 1,250,000   ACCRUAL   RESEARCH GRANT
(225) UNIVERSITY OF COLORADO DENVER
PO BOX 910238
DENVER,CO80291 		84-6000555 3 75,000   FMV   THERAPY ACCELERATION
(226) UNIVERSITY OF COLORADO DENVER ANSC
ANSCHUTZ MEDICAL CAMPUS BLDG 500 R
AURORA,CO80045 		84-0166760 3 200,000   ACCRUAL   RESEARCH GRANT
(227) UNIVERSITY OF CONNECTICUT HEALTH CE
263 FARMINGTON AVENUE
FARMINGTON,CT060302806 		57-1725543 3 337,033   ACCRUAL   RESEARCH GRANT
(228) UNIVERSITY OF FLORIDA
RESEARCH GRADUATE PROGRAMS 219 G
GAINESVILLE,FL32610 		59-6002052 3 110,000   ACCRUAL   RESEARCH GRANT
(229) UNIVERSITY OF FLORIDA
RESEARCH GRADUATE PROGRAMS 219 G
GAINESVILLE,FL32610 		59-6002052 3 379,475   ACCRUAL   RESEARCH GRANT
(230) UNIVERSITY OF MARYLAND
3112 LEE BUIDLING
COLLEGE PARK,MD20742 		52-6002033 3 200,000   ACCRUAL   RESEARCH GRANT
(231) UNIVERSITY OF MARYLAND BALTIMORE
RESEARCH ADMINISTRATION SUITE N9E1
BALTIMORE,MD21201 		52-6002033 3 200,000   ACCRUAL   RESEARCH GRANT
(232) UNIVERSITY OF MASSACHUSETTS MEDICAL
OFFICE OF RESEARCH RESEARCH FUNDIN
WORCESTER,MA01655 		04-3167352 3 200,000   ACCRUAL   RESEARCH GRANT
(233) UNIVERSITY OF MASSACHUSETTS MEDICAL
OFFICE OF RESEARCH RESEARCH FUNDIN
WORCESTER,MA01655 		04-3167352 3 110,000   ACCRUAL   RESEARCH GRANT
(234) UNIVERSITY OF MASSACHUSETTS MEDICAL
OFFICE OF RESEARCH RESEARCH FUNDIN
WORCESTER,MA01655 		04-3167352 3 110,000   ACCRUAL   RESEARCH GRANT
(235) UNIVERSITY OF MASSACHUSETTS MEDICAL
OFFICE OF RESEARCH RESEARCH FUNDIN
WORCESTER,MA01655 		04-3167352 3 55,000   ACCRUAL   RESEARCH GRANT
(236) UNIVERSITY OF MASSACHUSETTS MEDICAL
OFFICE OF RESEARCH RESEARCH FUNDIN
WORCESTER,MA01655 		04-3167352 3 110,000   ACCRUAL   RESEARCH GRANT
(237) UNIVERSITY OF MASSACHUSETTS MEDICAL
OFFICE OF RESEARCH RESEARCH FUNDIN
WORCESTER,MA01655 		04-3167352 3 55,000   ACCRUAL   RESEARCH GRANT
(238) UNIVERSITY OF MINNESOTA TWIN CITIE
OFFICE OF SPONSORED PROJECTS ADMINI
MINNEAPOLIS,MN55455 		41-6007513 3 200,000   ACCRUAL   RESEARCH GRANT
(239) UNIVERSITY OF NEBRASKA MEDICAL CENT
985100 NEBRASKA MEDICAL CENTER
OMAHA,NE681985100 		47-0049123 3 200,000   ACCRUAL   RESEARCH GRANT
(240) UNIVERSITY OF NORTH CAROLINA AT CHA
104 AIRPORT DRIVE SUITE 2200 CB 1
CHAPEL HILL,NC275991350 		56-6001393 3 65,000   ACCRUAL   RESEARCH GRANT
(241) UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET ROOM P-221
PHILADELPHIA,PA191046205 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(242) UNIVERSITY OF PENNSYLVANIA - SCHOOL
295 JOHN MORGAN BUILDING 3620 HAMI
PHILADELPHIA,PA19104 		23-1352685 3 110,000   ACCRUAL   RESEARCH GRANT
(243) UNIVERSITY OF ROCHESTER
OFFICE OF RESEARCH PROJECT ADMINI
ROCHESTER,NY14627 		16-0743209 3 200,000   ACCRUAL   RESEARCH GRANT
(244) UNIVERSITY OF SOUTH CAROLINA
901 SUMTER STREET 5TH FL
COLUMBIA,SC29208 		57-6001153 3 21,945   ACCRUAL   RESEARCH GRANT
(245) UNIVERSITY OF SOUTHERN CALIFORNIA
2250 ALCAZAR STREET CONTRACTS GR
LOS ANGELES,CA90033 		95-1642394 3 65,000   ACCRUAL   RESEARCH GRANT
(246) UNIVERSITY OF SOUTHERN CALIFORNIA
2250 ALCAZAR STREET CONTRACTS GR
LOS ANGELES,CA90033 		95-1642394 3 400,000   ACCRUAL   RESEARCH GRANT
(247) UNIVERSITY OF TEXAS SOUTHWESTERN ME
5323 HARRY HINES BLVD
DALLAS,TX753909020 		75-6002868 3 110,000   ACCRUAL   RESEARCH GRANT
(248) UNIVERSITY OF TEXAS SOUTHWESTERN ME
5323 HARRY HINES BLVD
DALLAS,TX753909020 		75-6002869 3 200,000   ACCRUAL   RESEARCH GRANT
(249) UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE RM 145
SALT LAKE CITY,UT841129003 		87-6000525 3 352,404   ACCRUAL   RESEARCH GRANT
(250) UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE RM 145
SALT LAKE CITY,UT841129003 		87-6000525 3 65,000   ACCRUAL   RESEARCH GRANT
(251) UNIVERSITY OF VIRGINIA
DIRECTOR OFFICE OF SPONSORED PROGRA
CHARLOTTESVILLE,VA22904 		23-7173411 3 200,000   ACCRUAL   RESEARCH GRANT
(252) UNIVERSITY OF WASHINGTON
UW GRANTS CONTRACT SERVICES 3935
SEATTLE,WA98195 		94-3079432 3 55,000   ACCRUAL   RESEARCH GRANT
(253) UNIVERSITY OF WASHINGTON
UW GRANTS CONTRACT SERVICES 3935
SEATTLE,WA98195 		94-3079432 3 200,000   ACCRUAL   RESEARCH GRANT
(254) VANDERBILT UNIVERSITY MEDICAL CENTE
3319 WEST END AVENUE SUITE 800
NASHVILLE,TN37232 		62-0476822 3 110,000   ACCRUAL   RESEARCH GRANT
(255) VIRGINIA COMMONWEALTH UNIVERSITY
SPONSORED PROGRAMS ADMINISTRATION
RICHMOND,VA232980568 		01-2201761 3 200,000   ACCRUAL   RESEARCH GRANT
(256) WAKE FOREST UNIVERSITY
CONTROLLERS OFFICE MEDICAL CENTER
WINSTONSALEM,NC27157 		56-0532138 3 200,000   ACCRUAL   RESEARCH GRANT
(257) WASHINGTON UNIVERSITY SCHOOL OF MED
SPONSORED PROJECTS ACCOUNTING 700
ST LOUIS,MO63110 		43-0653611 3 110,000   ACCRUAL   RESEARCH GRANT
(258) WASHINGTON UNIVERSITY SCHOOL OF MED
SPONSORED PROJECTS ACCOUNTING 700
ST LOUIS,MO63110 		43-0653611 3 399,756   ACCRUAL   RESEARCH GRANT
(259) WEILL CORNELL MEDICAL COLLEGE
1300 YORK AVENUE BOX 89
NEW YORK,NY100654805 		13-1623978 3 383,867   ACCRUAL   RESEARCH GRANT
(260) WEILL MED COLLEGE OF CORNELL
1300 YORK AVE
NEW YORK,NY10065 		13-1623978 3 600,000   FMV   THERAPY ACCELERATION
(261) WHITEHEAD INSTITUTE FOR BIOMEDICAL
9 CAMBRIDGE CENTER
CAMBRIDGE,MA021421479 		06-1043412 3 110,000   ACCRUAL   RESEARCH GRANT
(262) WHITEHEAD INSTITUTE FOR BIOMEDICAL
9 CAMBRIDGE CENTER
CAMBRIDGE,MA021421479 		06-1043412 3 55,000   ACCRUAL   RESEARCH GRANT
(263) YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTS PO BO
NEW HAVEN,CT065208327 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(264) CELATOR PHARMACEUTICALS INC
200 PRINCETON SOUTH CORPORATE CENTE
EWING,NJ08628 		20-2680869   274,256   FMV   THERAPY ACCELERATION
(265) CELATOR PHARMACEUTICALS INC
200 PRINCETON SOUTH CORPORATE CENTE
EWING,NJ08628 		20-2680869   900,000   FMV   THERAPY ACCELERATION
(266) CONSTELLATION PHARMACEUTICALS
215 FIRST STREET
CAMBRIDGE,MA02142 		26-1741721   775,000   FMV   THERAPY ACCELERATION
(267) CONSTELLATION PHARMACEUTICALS
215 FIRST STREET
CAMBRIDGE,MA02142 		26-1741721   775,000   FMV   THERAPY ACCELERATION
(268) FOX CHASE CANCER CENTER
604 COTTMAN AVE
CHELTENHAM,PA19012 		23-1352156   29,000   FMV   THERAPY ACCELERATION
(269) GOODWIN PROCTER LLP
53 STATE STREET
BOSTON,MA02109 		04-1378465   345,000   FMV   THERAPY ACCELERATION
(270) GOODWIN PROCTOR LLP
53 STATE STREET
BOSTON,MA02109 		04-1378465   345,000   FMV   THERAPY ACCELERATION
(271) MILESTONE1 KITE PHARMA
2225 COLORADO AVE
SANTA MONICA,CA90404 		27-1524986   500,000   FMV   THERAPY ACCELERATION
(272) NANOSYN INC
3100 CENTRAL EXPRESSWAY
SANTA CLARA,CA95051 		86-0909295   264,490   FMV   THERAPY ACCELERATION
(273) STEMLINE THERAPEUTICS INC
750 LEXINGTON AVE
NEW YORK,NY10022 		45-0522567   500,000   FMV   THERAPY ACCELERATION
(274) STEMLINE THERAPEUTICS INC
750 LEXINGTON AVE
NEW YORK,NY10022 		45-0522567   1,000,000   FMV   THERAPY ACCELERATION
(275) VALOR BIOTHERAPEUTICS
8800 HSC PARKWAY
BRYAN,TX77807 		46-1883738   100,000   FMV   THERAPY ACCELERATION
(276) VALOR BIOTHERAPEUTICS
8800 HSC PARKWAY
BRYAN,TX77807 		46-1883738   200,000   FMV   THERAPY ACCELERATION
(277) VALOR BIOTHERAPEUTICS
8800 HSC PARKWAY
BRYAN,TX77807 		46-1883738   100,000   FMV   THERAPY ACCELERATION
(278) VALOR BIOTHERAPEUTICS
8800 HSC PARKWAY
BRYAN,TX77807 		46-1883738   200,000   FMV   THERAPY ACCELERATION
(279) VALOR BIOTHERAPEUTICS
8800 HSC PARKWAY
BRYAN,TX77807 		46-1883738   1,000,000   FMV   THERAPY ACCELERATION
(280) VELESCO PHARMACEUTICAL SERVICE
46701 N COMMERCE CENTER DRIVE
PLYMOUTH,MI48170 		26-1330932   22,920   FMV   THERAPY ACCELERATION
(281) VELESCO PHARMACEUTICAL SERVICE
46701 N COMMERCE CENTER DRIVE
PLYMOUTH,MI48170 		26-1330932   20,219   FMV   THERAPY ACCELERATION
(282) VELESCO PHARMACEUTICAL SERVICE
46701 N COMMERCE CENTER DRIVE
PLYMOUTH,MI48170 		26-1330932   9,018   FMV   THERAPY ACCELERATION
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................ Bullet Image
102
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
9
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2014

Schedule I (Form 990) 2014
Page 2
Part III
Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a)Type of grant or assistance (b)Number of
recipients		 (c)Amount of
cash grant		 (d)Amount of
non-cash assistance		 (e)Method of valuation (book,
FMV, appraisal, other)		 (f)Description of non-cash assistance
(1) PATIENT FINANCIAL AID 808 111,525      
(2) COPAY ASSISTANCE CLL 2168 3,686,309      
(3) COPAY ASSISTANCE LYMPHOMA 7746 8,791,634      
(4) COPAY ASSISTANCE MDS 1603 3,592,561      
(5) COPAY ASSISTANCE MYELOMA 6658 22,228,870      
(6) COPAY ASSISTANCE MANTEL 500 1,305,000      
(7) COPAY ASSISTANCE CML 1191 2,006,405      
(8) COAPY ASSISTANCE ALL 34 80,550      
(9) COPAY ASSISTANCE WALDENST 22 114,152      
(10) PATIENT TRAVEL ASSISTNCE 633 318,255      
Part IV
Supplemental Information. Provide the information required in Part I, line 2, Part III, column (b), and any other additional information.
Return Reference Explanation
SCHEDULE I, PAGE 1, PART I, LINE 2 FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. PATIENT FINANCIAL AID: THE LEUKEMIA AND LYMPHOMA SOCIETY (LLS) REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR MANY EXPENSES RELATED TO THEIR TREATMENT. SOMETIMES PATIENTS HAVE TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE TREATMENT EXPENSES. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, LLS HAS ESTABLISHED A PATIENT FINANCIAL AID PROGRAM THAT PROVIDES APPLICANTS, WHO RESIDE IN THE US AND HAVE A BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND TO HELP DEFER SOME OF THESE EXPENSES. LLS ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA. CO-PAY ASSISTANCE: PATIENT APPLICATIONS ARE PROCESSED ON A FIRST COME, FIRST SERVED BASIS. ELIGIBLE PATIENTS MUST RESIDE IN THE UNITED STATES OR PUERTO RICO, HAVE A PROGRAM COVERED BLOOD CANCER DIAGNOSIS CONFIRMED BY A PHYSICIAN, MAINTAIN MEDICAL/PRESCRIPTION INSURANCE AND HAVE HOUSEHOLD INCOME AT OR BELOW 500% OF THE US FEDERAL POVERTY LEVEL AS ADJUSTED BY HOUSEHOLD SIZE AND COST OF LIVING INDEX. PATIENTS MUST PROVIDE PROOF OF INSURANCE AND INCOME. QUALIFYING PATIENTS ARE APPROVED FOR A TWELVE MONTH COVERAGE PERIOD. PATIENT TRAVEL ASSISTANCE: THE LEUKEMIA AND LYMPHOMA SOCIETY (LLS) REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR TRANSPORTATION TO GET TO THEIR PROVIDERS, E.G. DOCTORS, HOSPITALS, TRANSPLANT CENTERS, AND RESEARCH OR CLINICAL TRIAL CENTERS. SOMETIMES PATIENTS HAVE TO TRAVEL OUT-OF-STATE TO GET THEIR PRESCRIBED AND RECOMMENDED TREATMENTS, OFTENTIMES RESULTING IN PATIENTS HAVING TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, LLS ESTABLISHED THE TRAVEL ASSISTANCE PROGRAM WHICH PROVIDES APPLICANTS, WHO ARE US CITIZENS OR PERMANENT RESIDENTS, HAVE AN ANNUAL INCOME AT OR BELOW 500% OF THE FEDERAL POVERTY LEVEL (FPL) AND HAVE A CONFIRMED BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND TO HELP DEFER SOME OF THESE EXPENSES. LLS ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA.
Schedule I (Form 990) 2014


Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" to Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990.
SchJMediumBullet Information about Schedule J (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..
2
 
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? ................
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
Yes
 
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ...........................
5a
 
No
b
Any related organization? .........................
5b
 
No
If "Yes," to line 5a or 5b, describe in Part III.
6
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ...........................
6a
 
No
b
Any related organization? .........................
6b
 
No
If "Yes," to line 6a or 6b, describe in Part III.
7
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
Yes
 
8
Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................
8
 
No
9
If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2014

Schedule J (Form 990) 2014
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation in column(B) reported as deferred in prior Form 990
(i) Base compensation (ii) Bonus & incentive compensation (iii) Other reportable compensation
1LOUIS J DEGENNAROPRESIDENT & CEO (i)
(ii)		 433,871
...............................
  		 
...............................
  		23,963
...............................
  		84,300
...............................
  		28,674
...............................
  		570,808
...............................
  		 
...............................
 
2ROSEMARIE A LOFFREDOEVP-CAO & CFO (i)
(ii)		 300,560
...............................
  		 
...............................
  		11,632
...............................
  		10,150
...............................
  		14,666
...............................
  		337,008
...............................
  		 
...............................
 
3GORDON MILLER JRSVP FINANCE (i)
(ii)		 210,677
...............................
  		 
...............................
  		9,439
...............................
  		19,400
...............................
  		27,940
...............................
  		267,456
...............................
  		 
...............................
 
4MARK ROITHMAYREVP-CHIEF DEVEL OFF (i)
(ii)		 343,206
...............................
  		 
...............................
  		10,554
...............................
  		17,976
...............................
  		32,057
...............................
  		403,793
...............................
  		 
...............................
 
5GEORGE J OMIROS-TERM APR15EVP-CHIEF CAMP&FIELD (i)
(ii)		 306,618
...............................
  		 
...............................
  		11,698
...............................
  		28,111
...............................
  		22,014
...............................
  		368,441
...............................
  		 
...............................
 
6BRIAN ROSEN - TERM FEB15CHIEF POLICY & ADVOC (i)
(ii)		 255,063
...............................
  		25,000
...............................
  		12,547
...............................
  		18,776
...............................
  		10,873
...............................
  		322,259
...............................
  		5,594
...............................
 
7LEE M GREENBERGERSVP & CHIEF SCIENTIF (i)
(ii)		 272,769
...............................
  		 
...............................
  		11,397
...............................
  		10,006
...............................
  		32,899
...............................
  		327,071
...............................
  		 
...............................
 
8JEFFREY COMO-TERM DEC14CHIEF INFORM.OFFICER (i)
(ii)		 81,125
...............................
  		50,000
...............................
  		307,345
...............................
  		20,518
...............................
  		1,389
...............................
  		460,377
...............................
  		 
...............................
 
9LISA STOCKMON - TERM SEPT14EVP-CHIEF MARK.OFFIC (i)
(ii)		 219,789
...............................
  		 
...............................
  		59,141
...............................
  		8,750
...............................
  		12,609
...............................
  		300,289
...............................
  		18,749
...............................
 
10GABRIELLE URQUHART-TERM JUN15REGIONAL VP (i)
(ii)		 210,453
...............................
  		25,000
...............................
  		1,923
...............................
  		9,653
...............................
  		10,294
...............................
  		257,323
...............................
  		 
...............................
 
11JOHN E WALTER - TERM FEB14FORMER PRES & CEO (i)
(ii)		 54,230
...............................
  		 
...............................
  		785,660
...............................
  		1,458
...............................
  		22,896
...............................
  		864,244
...............................
  		156,240
...............................
 
Schedule J (Form 990) 2014

Schedule J (Form 990) 2014
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.
Return Reference Explanation
SCHEDULE J, PAGE 1, PART I, LINE 4 LOUIS J. DEGENNARO 0 50,000 0 JEFFREY COMO-TERM DEC14 130,452 0 0 JOHN E. WALTER - TERM FEB14 592,172 0 0
SCHEDULE J, PAGE 1, PART I, LINE 7 BONUSES WERE PAID BASED ON THE ACHIEVEMENT OF THE OVERALL ORGANIZATION'S OPERATING PLAN, EMPLOYEE INDIVIDUAL PERFORMANCE AND OTHER METRICS. BONUSES WERE CAPPED ACCORDING TO LLS'S POLICY. THESE AMOUNTS ARE REPORTED ON SCHEDULE J PART II, COLUMN (B)(II).
Schedule J (Form 990) 2014

Additional Data


Software ID:  
Software Version:  
SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
Noncash Contributions
Right pointing arrow large imageComplete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
Right pointing arrow large imageInformation about Schedule M (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of contributions or items contributed 		(c)
Noncash contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
noncash contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		     
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded . X 141 969,388 MARKET VALUE
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ... X 48    
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( PRINTED ITEMS ) X 11    
26 Other Right pointing arrow large image ( VARIOUS ) X 48    
27 Other Right pointing arrow large image( )
28 Other Right pointing arrow large image ( )
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement ...
29
 
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that
it must hold for at least three years from the date of the initial contribution, and which is not required to be used
for exempt purposes for the entire holding period? ..................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any non-standard contributions?
31
Yes
 
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash
contributions? ..........................
32a
 
No
b
If "Yes," describe in Part II.
33
If the organization did not report an amount in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) (2014)
Schedule M (Form 990) (2014)
Page 2
Part II
Supplemental Information. Provide the information required by Part I, lines 30b,
32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.
Return Reference Explanation
SCHEDULE M, PAGE 2, PART II PART I, COLUMN (B) LLS IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS. PART I, LINE 33 - EXPLANATION FOR NOT REPORTING REVENUE LLS ONLY RECORDS DONATED SECURITIES AS REVENUE. ALL OTHER ITEMS FOR WHICH COLUMN A IS CHECKED ARE NOT RECORDED AS REVENUE OR EXPENSE BECAUSE THEY WOULD NOT HAVE BEEN PURCHASED HAD THEY NOT BEEN DONATED, AND ARE IMMATERIAL IN AMOUNT RELATIVE TO THE STATEMENTS OF LLS.
Schedule M (Form 990) (2014)
Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
MediumBullet Information about Schedule O (Form 990 or 990-EZ) and its instructions is at
www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Return Reference Explanation
FORM 990, PAGE 2, PART III, LINE 4A WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2015, LLS SUPPORTED RESEARCH IN THE U.S., CANADA AND 7 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY 65 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: - BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. - TURNING DISCOVERIES INTO NEW THERAPIES: FUNDAMENTAL NEW FINDINGS CAN BE TRANSLATED INTO SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. - SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. - FILLING A VOID: RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY GOVERNMENT AGENCIES OR FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. - SPEEDING NEW TREATMENTS TO PATIENTS: PARTNERING WITH BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES CAN ADVANCE PROMISING THERAPIES THROUGH CLINICAL TESTING, FASTER. PAST ADVANCES MADE WITH LLS RESEARCH FUNDING GENEROUS DONORS HAVE HELPED LLS SUPPORT RESEARCH THAT HAS ALREADY BENEFITED BLOOD CANCER PATIENTS AND MANY OTHERS. ADVANCES INCLUDE: - MULTI-DRUG THERAPIES THAT ARE MORE EFFECTIVE THAN TREATMENTS WITH SINGLE ANTI-CANCER AGENTS, - BONE MARROW / STEM CELL TRANSPLANTATION AND SUPPORTIVE CARE TREATMENTS FOR PATIENTS WHO RELAPSE DESPITE THE BEST AVAILABLE THERAPY, AND, - TESTS THAT DISTINGUISH SPECIFIC CHARACTERISTICS OF PARTICULAR BLOOD CANCERS FOR ACCURATE DIAGNOSIS OF CANCER SUBTYPES, AND FOR "RISK STRATIFICATION" TO SELECT AN OPTIMAL THERAPY. TARGETED THERAPY RESEARCH DISCOVERING THE MOLECULAR ABNORMALITIES THAT CAUSE PARTICULAR TYPES OF BLOOD CANCER HAS BEEN USEFUL IN DIAGNOSIS AND RISK STRATIFICATION, AND IN NEW "TARGETED DRUG" DEVELOPMENT. LLS-FUNDED INVESTIGATORS HAVE HELPED ADVANCE MOLECULARLY TARGETED TREATMENTS THAT CAN SELECTIVELY KILL BLOOD CANCER CELLS VERSUS NORMAL CELLS. MANY OF THESE NEW TREATMENTS BENEFIT NOT ONLY BLOOD CANCER PATIENTS, BUT ALSO PATIENTS WITH OTHER DISEASES. FOR EXAMPLE: - GLEEVEC IS FDA-APPROVED FOR PATIENTS OF ALL AGES WITH CHRONIC MYELOID LEUKEMIA (CML), AND IS ALSO APPROVED FOR PATIENTS WITH ONE FORM OF ACUTE LYMPHOID LEUKEMIA (ALL), MYELODYSPLASTIC SYNDROMES (MDS), MYELOPROLIFERATIVE DISORDERS AND RARE FORMS OF STOMACH AND SKIN CANCERS. RELATED DRUGS, SPRYCEL AND TASIGNA, ARE APPROVED FOR PATIENTS WHO DO NOT BENEFIT FROM GLEEVEC. ONE OR MORE OF THESE DRUGS ARE ALSO SHOWING PROMISE FOR PATIENTS WITH VARIOUS LYMPHOMAS, ACUTE MYELOID LEUKEMIA (AML), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND OTHER CANCERS, INCLUDING BRAIN, BREAST, HEAD-AND-NECK, LUNG, PANCREATIC, AND PROSTATE CANCERS, AND PATIENTS WITH OTHER DISEASES INCLUDING ALZHEIMER'S, ASTHMA AND PULMONARY HYPERTENSION. - RITUXAN WAS THE FIRST FDA-APPROVED, ANTI-CANCER ANTIBODY DRUG, DEVELOPED FOR PATIENTS WITH FORMS OF B-CELL NON-HODGKIN LYMPHOMA (NHL). IT IS NOW ALSO APPROVED FOR CLL PATIENTS AND AS A "MAINTENANCE" THERAPY FOR FOLLICULAR LYMPHOMA PATIENTS, AND SHOWING PROMISE FOR PATIENTS WITH ALL AND AFTER STEM CELL TRANSPLANTATION. IN ADDITION, IT IS APPROVED FOR TREATING PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS AND TWO OTHER TYPES OF AUTOIMMUNE DISEASES. A RELATED ANTIBODY DRUG, ARZERRA, IS APPROVED FOR CLL PATIENTS AND SHOWING WIDER PROMISE. - VELCADE, THALIDOMID AND REVLIMID ARE FDA-APPROVED FOR PATIENTS WITH MYELOMA AND ARE ALSO HELPING SOME PATIENTS WITH HODGKIN LYMPHOMA AND NHL. KRYPOLIS WAS RECENTLY APPROVED FOR MYELOMA PATIENTS FOR WHOM AT LEAST TWO PRIOR THERAPIES WERE INSUFFICIENT. ONE OR MORE OF THESE DRUGS ARE NOW BEING TESTED FOR PATIENTS WITH T-CELL AND B-CELL FORMS OF LYMPHOMA, ACUTE LEUKEMIAS, AS WELL AS AIDS-RELATED KAPOSI SARCOMA AND BRAIN, BREAST, COLORECTAL, HEAD-AND-NECK, KIDNEY, LIVER, LUNG, OVARIAN AND PROSTATE CANCERS, AND ALZHEIMER'S DISEASE. - ISTODAX, ZOLINZA, DACOGEN AND VIDAZA TARGET SMALL CHEMICAL, "EPIGENETIC" CHANGES. THE FIRST TWO DRUGS ARE APPROVED FOR PATIENTS WITH PERIPHERAL T-CELL LYMPHOMAS; THE LATTER DRUGS ARE APPROVED FOR MDS PATIENTS. ONE OR MORE OF THESE DRUGS ARE BEING TESTED FOR PATIENTS WITH ALL, AML, CML, CLL, MYELOMA AND FORMS OF NHL, AFTER STEM CELL TRANSPLANTATION, AND FOR PATIENTS WITH BREAST, BRAIN, KIDNEY, COLORECTAL, HEAD-AND-NECK, LUNG, STOMACH, PROSTATE AND OVARIAN CANCERS, MELANOMA AS WELL AS SICKLE CELL DISEASE AND PERSISTENT HIV INFECTIONS. - ADCETRIS WAS APPROVED IN 2011, AND IN JANUARY 2012. IT IS AN ANTIBODY- DRUG CONJUGATE THAT COMBINES AN ANTI-CD30 ANTIBODY AND THE CYTOTOXIC DRUG MONOMETHYL AURISTATIN E (MMAE). IT IS AN ANTI-NEOPLASTIC AGENT USED IN THE TREATMENT OF HODGKIN LYMPHOMA AFTER FAILURE OF AUTOLOGOUS STEM CELL TRANSPLANT OR THOSE WHO ARE NOT ELIGIBLE FOR ASCT AFTER FAILURE OF AT LEAST 2 MUTIAGEN CHEMOTHERAPY REGIMENS. ADCETRIS WAS ALSO APPROVED FOR SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA WITH FAILURE OF AT LEAST ONE PRIOR TREATMENT. - GAZYVA IS A HUMANIZED MONOCLONAL ANTIBODY USED AS A COMBINATION TREATMENT WITH CHLORAMBUCIL TO TREAT PATIENTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA. IT WAS APPROVED BY THE FDA IN NOVEMBER 2013 AND BY THE EHA IN JULY 2014. - IMBRUVICA IS AN ORAL SMALL MOLECULE INHIBITOR AGIANST BTK KINASE. IT WAS FIRST APPROVED BY THE US FDA ON NOVEMBER 13, 2013 FOR THE TREATMENT OF MANTLE CELL LYMPHOMA PATIENTS WHO HAVE RECIEVED AT LEAST ONE PRIOR TREATMENT. ON FEB. 12, 2014 THE US FDA EXPANDED THE APPROVED USE OF THE DRUG TO CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR TREATMENT. ADDITIONALLY, IT RECEIVED FURTHER EXPANSION TO TREAT 17P DELETION IN CLL WITH OR WITHOUT PRIOR THERAPY. - ZYDELIG IS AN ORAL SMALL MOLECULE INHIBITOR THAT BLOCKS THE DELTA ISOFORM OF THE ENZYME PHOSPHOINOSITIDE 3-KINASE. IT WAS APPROVED BY THE FDA IN JULY 2014 TO TREAT RELAPSED/REFRACTORY CLL IN COMBINATION WITH RITUXAN. IT WAS ALSO APPROVED TO USE AS A MONOTHERAPY FOR RELAPSED MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA. OTHER ACTIVE RESEARCH DIRECTIONS LLS-FUNDED RESEARCHERS ARE ALSO EXPLORING OTHER AREAS OF RESEARCH THAT HOLD PROMISE FOR PATIENTS: - NOVEL STEM CELL TRANSPLANTATION PROCEDURES: THESE INCLUDE SO-CALLED "MINI" TRANSPLANTS THAT USE LESS TOXIC PRE-TRANSPLANT TREATMENTS AND ENGINEERED DONOR CELLS THAT HELP REDUCE POST-TRANSPLANT COMPLICATIONS, MAKING THESE POTENTIALLY CURATIVE TREATMENTS AVAILABLE TO MORE PATIENTS. - IMMUNOTHERAPIES: INCLUDING ANTIBODIES, VACCINES AND ENGINEERED IMMUNE CELLS, THESE TARGETED THERAPIES HELP A PATIENT'S IMMUNE SYSTEM FIGHT INFECTIONS AND KILL RESIDUAL CANCER CELLS, PROLONGING REMISSIONS, AND PERHAPS ONE DAY REPLACING TOXIC CHEMOTHERAPIES. - DIAGNOSTICS: NEW TECHNOLOGIES MAKE IT POSSIBLE TO CHARACTERIZE THE ABNORMALITIES IN INDIVIDUAL CANCER CASES IN MOLECULAR DETAIL. THIS INFORMATION CAN BE USED TO HELP CHOOSE THE BEST POSSIBLE TREATMENT FOR EACH PATIENT, ESPECIALLY AS MORE TARGETED THERAPIES BECOME AVAILABLE. - QUALITY OF LIFE RESEARCH: THESE STUDIES INCREASE OUR UNDERSTANDING OF HOW SPECIFIC TREATMENTS CAN CAUSE DEBILITATING SIDE-EFFECTS, INCLUDING LATE-EFFECTS, AND WHICH PATIENTS ARE AT RISK FOR DEVELOPING THESE COMPLICATIONS, SO THAT THEY CAN BE BETTER MANAGED OR EVEN PREVENTED. DRIVING RESEARCH TO ADDRESS UNMET MEDICAL NEEDS LLS CONTINUES TO SOLICIT AND SUPPORT RESEARCH FOCUSED ON IMPROVING BLOOD CANCER PATIENTS' QUALITY OF LIFE AFTER TODAY'S CURATIVE THERAPIES. ALSO IN 2015, FOR THE FOURTH YEAR, LLS ACTIVELY RECRUITED RESEARCH PROPOSALS IN SIX OTHER UNDERDEVELOPED RESEARCH AREAS IN WHICH PROGRESS IS LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. NEW RESEARCH IS FOCUSED ON: - DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES FOR PATIENTS WITH NON- CUTANEOUS T-CELL LYMPHOPROLIFERATIVE DISORDERS - DEVELOP NOVEL TARGETED THERAPIES FOR CLL PATIENTS, WITH REAL CURATIVE POTENTIAL - DEVELOP NOVEL TREATMENT STRATEGIES FOR MDS AND AML PATIENTS - DEVELOP NOVEL TARGETED THERAPIES FOR PATIENTS WITH HIGH-RISK MYELOMA - DEVELOPMENT OF NEW-TARGETED THERAPIES FOR INDOLENT LYMPHOMA PATIENTS - DEFINE GENETIC/MOLECULAR PREDISPOSITIONS TO LONG-TERM AND LATE-TERM EFFECTS ASSOCIATED WITH STANDARD THERAPIES IN PEDIATRIC ALL AND APPLY THIS INFORMATION TO IMPROVE PATIENT OUTCOMES. THE THERAPY ACCELERATION PROGRAM THIS STRATEGIC INITIATIVE WAS LAUNCHED IN 2007 TO MOVE NEW TREATMENTS AND DIAGNOSTICS THROUGH PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS, FASTER. USING MILESTONE-DRIVEN CONTRACTS AND WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS AND COMPANIES, LLS IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE AVAILABLE TO PATIENTS AS SOON
FORM 990, PAGE 2, PART III, LINE 4B A NUMBER OF RESOURCES ARE AVAILABLE IN SPANISH FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS. LLS PUBLISHES AN ANNUAL COMPILATION OF DATA AVAILABLE FOR BLOOD CANCERS, INCLUDING THE ESTIMATED NUMBERS OF NEW BLOOD CANCER CASES AND DEATHS, THE MOST RECENT STATISTICS AVAILABLE FOR INCIDENCE, MORTALITY AND SURVIVAL; AND CURRENT AND ACCURATE INFORMATION ABOUT SYMPTOMS, RISK FACTORS AND TREATMENT. PUBLICATIONS AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LLS CHAPTERS. MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH, SPANISH AND FRENCH. - 705,326 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2015. FINANCIAL ASSISTANCE IN 2015, A COMBINED 42,235,261 WAS DISBURSED TO PATIENTS THROUGH THE LLS PATIENT FINANCIAL AID (111,525),CO-PAY ASSISTANCE PROGRAMS (41,805,481) AND THE LLS NATIONAL PATIENT TRAVEL ASSISTANCE PROGRAM (318,255). CO-PAY ASSISTANCE PROGRAM THIS CO-PAY ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 19,922 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2015 COMMUNITY PROGRAMS EACH LLS CHAPTER OFFICE IS STAFFED WITH A PATIENT SERVICES MANAGER (PSM) WHO OVERSEES SERVICES TO PATIENTS AND THEIR FAMILIES, CAREGIVERS AND HEALTHCARE PROFESSIONALS. PSMS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. PSMS SERVE AS LIAISONS WITH COMMUNITY AND REGIONAL ONCOLOGY/HEMATOLOGY HEALTHCARE PROFESSIONALS AND TREATMENT CENTERS. COMMUNITY-BASED EDUCATION AND OUTREACH, SUPPORT AND PUBLIC POLICY AND ADVOCACY PROGRAMS ARE AVAILABLE. PATIENT EDUCATION PROGRAMS: IN 2015 WE CONDUCTED 221 LOCAL PATIENT EDUCATION PROGRAMS TO A TOTAL OF 9,807 ATTENDEES. THESE PROGRAMS RANGED FROM DISEASE SPECIFIC TOPICS TO THOSE OF SURVIVORSHIP. OF THE TOTAL ATTENDING THESE LOCAL EDUCATION PROGRAMS, A MAJORITY WERE PATIENTS AND CAREGIVERS (6,872 ATTENDEES) BUT IMPORTANTLY, MANY (2,404 ATTENDEES) WERE HEALTHCARE PROFESSIONALS. BLOOD CANCER CONFERENCES: LLS WORKS TO ELEVATE OUR VISIBILITY IN COMMUNITIES WE SERVE BY HOSTING LARGER-SCALE CONFERENCES, GEARED FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS. THESE EVENTS ARE A CATALYST FOR BRINGING MANY DEDICATED PEOPLE TOGETHER TO FOCUS ON BLOOD CANCER AWARENESS, INFORMATION AND THE LATEST ADVANCES IN MEDICAL SCIENCE. THEY ARE ALSO AN IMPORTANT SOURCE OF CONTINUING EDUCATION FOR MANY HEALTHCARE PROFESSIONALS. IN 2015, 25 BCC CONFERENCES WERE HELD WITH TOTAL ATTENDANCE OF 6,589. 2,965 WERE PATIENTS, 1,511 CAREGIVERS, 1,001 NURSES, 181 SOCIAL WORKS, 128 MEDICAL DOCTORS, AND 628 "OTHER" HEALTHCARE PROFESSIONALS SERVING THE UNDERSERVED: IN 2015, WE OFFERED 68 SPECIAL PROGRAMS TO PEOPLE WHO OFTEN DON'T HAVE THE SAME ACCESS TO INFORMATION AND SUPPORT AS OTHERS MIGHT HAVE. BREAKING DOWN ACCESS BARRIERS IN UNDERREPRESENTED POPULATIONS MEANS BLOOD CANCER PATIENTS GET THE INFORMATION AND SUPPORT THEY NEED. THIS OUTREACH BROUGHT IMPORTANT DISEASE TREATMENT INFORMATION TO MORE THAN 5,500 PEOPLE IN COMMUNITIES WE SERVE. OF THIS, 3,870 WERE PATIENTS AND CAREGIVERS, JOINED BY 1,126 HEALTHCARE PROFESSIONALS. MYELOPROLIFERATIVE NEOPLASMS OR MPN: IN 2015, LLS WAS ABLE TO OFFER SPECIALIZED MYELOPROLIFERATIVE NEOPLASMS OR MPN EDUCATION PROGRAMS IN FOUR COMMUNITIES TO A TOTAL OF 70 PATIENTS AND CAREGIVERS AND 9 HEALTHCARE PROFESSIONALS. IN ADDITION, LLS PROVIDED COMMUNITY-BASED EDUCATION CONCERNING THE LATEST CLINICAL TRIALS INFORMATION TO 634 PATIENTS AND CAREGIVERS, WHO WERE JOINED BY 286 HEALTHCARE PROFESSIONALS. FAMILY SUPPORT GROUPS: THROUGHOUT THE US, IN 2015, LLS SUPPORTED OR HOSTED 296 REGISTERED FAMILY SUPPORT GROUP MEETINGS FOR PATIENTS AND THEIR FAMILIES. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, PROVIDING INFORMATION AND SUPPORT AND ENCOURAGING GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTHCARE PROFESSIONALS. LLS SUPPORT GROUPS ARE THE PERFECT PLACE TO TALK WITH OTHER PEOPLE AFFECTED BY BLOOD CANCERS, INCLUDING PATIENTS, FAMILY MEMBERS AND CAREGIVERS. THE GROUPS PROVIDE MUTUAL SUPPORT AND OFFER THE OPPORTUNITY TO DISCUSS ANXIETIES AND CONCERNS WITH OTHERS WHO SHARE THE SAME EXPERIENCES. THIS SHARING STRENGTHENS THE FAMILY BOND AND ENHANCES EVERYONE'S ABILITY TO COPE WITH CANCER. PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM: FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 1,476 FIRST CONNECTIONS ACROSS THE US IN 2015.
FORM 990, PAGE 2, PART III, LINE 4C PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 9 P.M., ET, EMAIL INFOCENTER@LLS.ORG OR CHAT ONE-ON-ONE VIA THE LLS WEBSITE. THE INFORMATION RESOURCE CENTER OFFERS TRANSLATION SERVICES IN MORE THAN 165 LANGUAGES. - 31,511 INQUIRIES MADE TO OUR INFORMATION SPECIALISTS, AND 30,871 INQUIRIES MADE TO OUR PATIENT ACCESS STAFF ACROSS THE COUNTRY IN 2015. THE LLS WEBSITE THE LLS WEBSITE, WWW.LLS.ORG, FULFILLS A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. VISITORS CAN PERSONALIZE THEIR WEB PAGES TO THEIR LOCATION TO KEEP CURRENT WITH DISEASE-SPECIFIC UPDATES AND COMMUNITY EDUCATION AND SUPPORT ACTIVITIES. THE WEBSITE PROVIDES ACCESS TO LLS PROGRAMS AND SERVICES, INCLUDING CO-PAY ASSISTANCE, THE MOST CURRENT AND ACCURATE INFORMATION AND STATISTICS, WEEKLY FACILITATED ONLINE CHATS, NATIONAL TELEPHONE AND WEB EDUCATION PROGRAMS, PUBLICATIONS IN ENGLISH AND SPANISH, AND CLINICAL-TRIAL SEARCHES VIA AN ONLINE CLINICAL- TRIAL SEARCH SERVICE THAT OFFERS PATIENTS AND CAREGIVERS IMMEDIATE ACCESS TO LISTINGS OF BLOOD CANCER CLINICAL TRIALS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS AND ONE ANOTHER THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. NATIONAL TELEPHONE/ WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. IN 2015, 9 LLS NATIONAL EDUCATION PROGRAMS FEATURED DISEASE-SPECIFIC UPDATES AND INFORMATION ABOUT SUPPORT AND TREATMENT OPTIONS FROM WORLD RENOWNED CLINICAL EXPERTS. OPPORTUNITIES ARE PROVIDED TO ASK QUESTIONS OF EXPERTS DURING THESE PROGRAMS. THESE PROGRAMS OFFER CONTINUING EDUCATION CREDITS FOR NURSES AND SOCIAL WORKERS. LLS ALSO SPONSORS A RANGE OF PROFESSIONAL EDUCATION PROGRAMS. RECENT PROGRAMS EXPLORED THE ADMINISTRATION AND MANAGEMENT OF CURRENT THERAPIES FOR HEMATOLOGIC MALIGNANCIES AND COMMUNICATION AMONG PRIMARY CARE PROVIDERS AND HEMATOLOGISTS/ONCOLOGISTS IN MANAGING PATIENTS WITH HEMATOLOGIC CANCER. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. PROFESSIONAL EDUCATION PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PROFESSIONALED. LLS ALSO OFFERS DISEASE-SPECIFIC WEBCASTS PRESENTED BY WORLD RENOWNED CLINICAL EXPERTS. THESE CAN BE ACCESSED AT WWW.LLS.ORG/WEBCASTS.
FORM 990, PAGE 2, PART III, LINE 4D D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT.
FORM 990, PART V, LINE 4B CANADA
FORM 990, PAGE 6, PART VI, LINE 6 THE MEMBERS OF LLS CONSIST OF ONE ELECTED REPRESENTATIVE FROM EACH CHAPTER.
FORM 990, PAGE 6, PART VI, LINE 7A THE BOARD OF REPRESENTATIVES (REPRESENTING THE CHAPTERS) ELECTS THE MEMBERS OF LLS'S GOVERNING BODY, ITS NATIONAL BOARD OF DIRECTORS.
FORM 990, PAGE 6, PART VI, LINE 7B SIGNIFICANT DECISIONS AFFECTING THE CHAPTERS REQUIRE AN APPROVING VOTE BY THE CHAPTER DELEGATES. DECISIONS NOT SIGNIFICANTLY AFFECTING THE CHAPTERS DO NOT REQUIRE APPROVAL FROM THE CHAPTER DELEGATES.
FORM 990, PAGE 6, PART VI, LINE 11B THE FORM 990 WAS PREPARED BY THE LLS FINANCE DEPARTMENT AND WAS REVIEWED BY THE CAO & CFO, SR. VICE PRESIDENT OF FINANCE, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990 WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING BY POSTING THE FORM ON AN INTRANET WEBSITE.
FORM 990, PAGE 6, PART VI, LINE 12C ALL EMPLOYEES, BOARD OF DIRECTORS MEMBERS, BOARD OF REPRESENTATIVES MEMBERS, CHAPTER BOARD MEMBERS, FAMILY SUPPORT GROUP FACILITATORS, AND TNT COACHES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND SUBMIT A SIGNED FORM ACKNOWLEDGING THAT THEY HAVE REVIEWED THE POLICY AND DISCLOSED ANY CONFLICTS OF INTEREST. ALL FORMS ARE COLLECTED AND THE AUDIT COMMITTEE REVIEWS ANY FORMS DISCLOSING A POSSIBLE CONFLICT OF INTEREST AND DETERMINES WHETHER OR NOT A CONFLICT EXISTS. PART VI, LINE 12 C: ALL EMPLOYEES, BOARD OF DIRECTORS MEMBERS, BOARD OF REPRESENTATIVES ARE RECUSED FROM ANY DISCUSSION WHERE A CONFLICT OF INTEREST EXISTS. ANY QUESTIONS REGARDING COI WILL GO TO THE AUDIT COMMITTEE.
FORM 990, PAGE 6, PART VI, LINE 15A THE EXECUTIVE COMMITTEE COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS REVIEWS AND MONITORS THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. IN 2015 THE COMMITTEE OBTAINED A SURVEY OF OTHER NOT- FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE COMMITTEE MET AND REVIEWED THE COMPENSATION PACKAGE BUT IT WAS NOT INCLUDED IN THE COMMITTEE MINUTES.
FORM 990, PAGE 6, PART VI, LINE 15B THE EXECUTIVE COMMITTEE COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS REVIEWS AND MONITORS THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. IN 2015 THE COMMITTEE OBTAINED A SURVEY OF OTHER NOT- FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE COMMITTEE MET AND REVIEWED THE COMPENSATION PACKAGE BUT IT WAS NOT INCLUDED IN THE COMMITTEE MINUTES.
FORM 990, PAGE 6, PART VI, LINE 17 ILLINOIS, INDIANA, KANSAS, KENTUCKY, LOUISIANA, MASSACHUSETTS, MARYLAND, MAINE, MICHIGAN, MINNESOTA, MISSOURI, MISSISSIPPI, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEBRASKA, NEW YORK, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, PUERTO RICO, RHODE ISLAND, SOUTH CAROLINA, TENNESSEE, UTAH, VIRGINIA, WASHINGTON, WISCONSIN, WEST VIRGINIA
FORM 990, PAGE 6, PART VI, LINE 19 THE LEUKEMIA & LYMPHOMA SOCIETY, INC. MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT WWW.LLS.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990.
FORM 990, PART XI, LINE 9 LLS CANADA REVENUE 10,501,177 LLS CANADA GAIN ON INVESTMENT 177,817 LLS CANADA EXPENSES -10,122,744 FOREIGN CURRENCY TRANSLATION -530,316
FORM 990, PART XI, LINE 9 CANADA OPENING NET ASSETS ADJUSTMENTS 133,047 FINANCIAL STATEMENTS ROUNDING -61 LLS CANADA CHANGE IN NET ASSET -25,936 INC.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2014

Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBulletAttach to Form 990.
MediumBullet Information about Schedule R (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047
2014
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Identification of Disregarded Entities Complete if the organization answered "Yes" on Form 990, Part IV, line 33.
(a)
Name, address, and EIN (if applicable) of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income


 		(e)
End-of-year assets


 		(f)
Direct controlling
entity










Part II
Identification of Related Tax-Exempt Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section


 		(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled entity?
Yes No
(1) THE LLS OF CANADA
804 2 LANSING SQUARE
TORONTO   M2J4P8
CA
PART VII CA     NA
 
 
No
(2) THE LLS RESEARCH PROGRAMS INC
1311 MAMARONECK AVENUE

WHITE PLAINS,NY10605
13-3470494 		PART VII DE 501C3 11B LLS INC
 
Yes
 
(3) THE LLS RESEARCH FOUNDATION
1311 MAMARONECK AVENUE

WHITE PLAINS,NY10605
13-3709252 		PART VII DE 501C3 11B LLS INC
 
Yes
 








For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2014
Schedule R (Form 990) 2014
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V-UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.
(a)
Name, address, and EIN of
related organization
 		(b)
Primary activity
 		(c)
Legal
domicile
(state or foreign
country)
 		(d)
Direct controlling
entity
 		(e)
Type of entity
(C corp, S corp,
or trust) 		(f)
Share of total income
 		(g)
Share of end-of-year
assets
 		(h)
Percentage
ownership
 		(i)
Section 512(b)(13) controlled entity?
Yes No












Schedule R (Form 990) 2014
Schedule R (Form 990) 2014
Page 3
Part V
Transactions With Related Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.
Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .
1a
 
No
b Gift, grant, or capital contribution to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1b
 
No
c Gift, grant, or capital contribution from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1c
Yes
 
d Loans or loan guarantees to or for related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1d
Yes
 
e Loans or loan guarantees by related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1e
 
No
f Dividends from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1f
 
No
g Sale of assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1g
 
No
h Purchase of assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1h
 
No
i Exchange of assets with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1i
 
No
j Lease of facilities, equipment, or other assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1j
 
No
k Lease of facilities, equipment, or other assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .
1k
 
No
l Performance of services or membership or fundraising solicitations for related organization(s) . . . . . . . . . . . . . . . . . . . .
1l
 
No
m Performance of services or membership or fundraising solicitations by related organization(s) . . . . . . . . . . . . . . . . . . . .
1m
 
No
n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) . . . . . . . . . . . . . . . . . . . . .
1n
Yes
 
o Sharing of paid employees with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1o
Yes
 
p Reimbursement paid to related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1p
 
No
q Reimbursement paid by related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1q
 
No
r Other transfer of cash or property to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1r
 
No
s Other transfer of cash or property from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1s
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of related organization 		(b)
Transaction
type (a-s) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) THE LEUKEMIA & LYMPHOMA SOCIETY

 D 38,116 COST
(2) OF CANADA

      




Schedule R (Form 990) 2014
Schedule R (Form 990) 2014
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 37.
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Predominant income (related, unrelated, excluded from tax under sections 512-514)

(e)
Are all partners
section
501(c)(3)
organizations? 		(f)
Share of total income




 		(g)
Share of
end-of-year
assets 		(h)
Disproprtionate allocations? 		(i)
Code V-UBI
amount in box 20
of Schedule K-1
(Form 1065) 		(j)
General or
managing
partner? 		(k)
Percentage
ownership
Yes No Yes No Yes No






























Schedule R (Form 990) 2014
Schedule R (Form 990) 2014
Page 5
Part VII
Supplemental Information
Provide additional information for responses to questions on Schedule R (see instructions).
Return Reference Explanation
SCHEDULE R THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA CARRIES OUT THE SAME PRIMARY ACTIVITIES AS THE LEUKEMIA & LYMPHOMA SOCIETY, INC., IN CANADA. THE LEUKEMIA SOCIETY RESEARCH PROGRAMS, INC. AND THE LEUKEMIA RESEARCH FOUNDATION, INC. SUPPORT THE ACTIVITIES OF THE LEUKEMIA & LYMPHOMA SOCIETY, INC.
Schedule R (Form 990) 2014
Additional Data


Software ID:  
Software Version: